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ABSTRACT 
Engineering of 3D scaffolds for tissue repair requires the ability to align cells to mimic 
cell orientations of native tissues. Our study focused on utilizing electrospinning technology to 
develop 3D nanofiber scaffolds whose alignment can be customized to mimic the 
microarchitecture of a tissue. Current electrospinning techniques have limited control of fiber 
orientation. We engineered a collection plate that can be adapted to produce 3D biomaterial 
scaffolds for use with commercially available electrospinning units. The custom fiber aligned 
scaffolds were seeded with green fluorescent protein (GFP) expressing cells to show viability for 
cell seeding and alignment along the fiber direction. The major device design characteristics and 
results are presented in this report. 
  
14 
 
1. INTRODUCTION 
One of the more common knee ailments that affect individuals of all activity levels is a 
meniscal tear. Though often resulting from sport-related incidents, this injury can occur from 
simple twisting and pressure-inducing movements of the knee. Meniscal surgeries are performed 
on roughly 1 million patients annually in the United States alone, generating a $4 billion market 
(Frizziero et al., 2012). The majority of the meniscus is avascular with the exception the 
peripheral regions, specifically 20-30% of the medial and 10-25% of the lateral meniscus, 
meaning that all other regions are unable to repair self-sufficiently without vascular networks to 
facilitate nutrient perfusion. Therefore, there is a need for a novel tissue scaffold capable of 
fostering cell growth and proliferation in 3D environments to test the viability of a complete 
meniscus repair under in vitro conditions.  
Several treatment options are available for meniscus repair based on the severity. 
Physical therapy is the initial and ideal choice of treatment for mild injuries. All other treatments 
are surgical, varying in the amount of intervention. Repair can be partial, subtotal, or total 
replacement of the cartilage. Partial surgery is the most common procedure. Surgeons create 
incisions in the meniscus and insert sutures as a fixation method. This ensures that adequate 
mobility is present, referencing a 2 to 5 mm translation medially and 9 to 11 mm laterally to 
model in vivo conditions (Baker, 2015). However treatment complications are commonplace, 
often negatively impacting the weight distribution in the knee post-surgery. These imbalances 
also directly cause bone-on-bone contact, known as osteoarthritis, which leads to cartilage 
degradation. 
        Anatomically, the lateral section covers the front of the knee while the medial lies in the 
middle of the meniscus. 
15 
 
 
Figure 1: Diagram detailing different areas and connections of the meniscus 
(Physical Healthcare, 2016) 
From a cross-sectional viewpoint, the outer region of the meniscus is filled with long oval shaped 
cells, shaped for communication, whereas the inner region is comprised of round cells in the 
extracellular matrix, specifically fibrochondrocytes, and chondrocytes (Markis et al., 2012). 
        The injury rate demonstrates the need for a biocompatible, naturally constructed tissue-
engineered scaffold both for in vitro research and for meniscal implantation. A properly 
engineered meniscus would inhibit imbalances in the knee from forming, while allowing for full 
functionality. Current meniscus repairs are not customizable. A standardized procedure to 
engineer menisci in vitro could lead to the development of customized menisci based on patient-
specific MRIs. A commercially available meniscus, Menaflex, developed by ReGen Biologics 
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was originally approved by the FDA but has since been retracted. Another product, Actifit, 
developed by Orteq has not yet been cleared by the FDA for full replacements. Additionally, the 
major drawback of the current scaffold designs is the shared inability to provide sufficient 
vasculature to allow proper nutrient diffusion needed for the facilitation, growth and 
maintenance of the menisci cells and its matrix. 
This project hones in on development of a universal tissue scaffold to further meniscus 
repair research, which can be tailored to individual patients in the future. The biomaterials 
chosen need to be compatible with the cellular microenvironment to allow for tissue formation. 
The scaffold must facilitate alignment of cells to imitate the micro-geometries and 
microarchitecture of the meniscal tissue to promote normal functioning of the tissue. In order for 
an engineered tissue to be successful, it is important to ensure proper alignment of cells in a three 
dimensional environment, which mimic the 3D micro architecture and micro-geometries similar 
to the tissue of origin. For a load bearing tissue such as the meniscus, mechanical stimulation and 
conditioning will be necessary before implantation so that the meniscus will behave effectively 
in the day to day activities of the patient.  
A meniscus in the natural environment experiences enormous amounts of shear, tensile, 
and compressive forces.  A tissue-engineered meniscus must withstand certain parameters to be 
considered implantable. These parameters are a shear stress of 120 KPa, tensile force of 100-300 
MPa, and compressive forces ranging from 100-150 KPa (Markis et al., 2012). 
To achieve these specifications, the project must meet established milestones. Research 
needs to be conducted on which biomaterials are to be utilized in the scaffold as well as how the 
scaffold will guide cells into an alignment that mimics nature. In this project, our team aims to 
design a biomorphic meniscal scaffold that will closely mimic the fiber and cell alignment whose 
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function should resemble the native tissue. The design process and design alternatives are 
presented in this report and discussed in detail.   
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2. LITERATURE REVIEW 
An extensive literature review was done in order to determine the anatomy/functions of 
the meniscus, types of injuries, their treatment options and complications, and relevance. Tissue 
engineering strategies and the current state of the art are also reviewed in this chapter. 
2.1. Function of the Meniscus 
The primary functions of the meniscus consist of (1) load transmission, (2) shock 
absorption, and (3) lubrication, with some capacity to support knee stability. All of these 
functions must be considered and the detailed means must be analyzed within the scope of our 
project to ensure that our testing and validation methods are physiologically accurate and 
feasible. 
In analyzing the mobile segment of the meniscus, we discovered that depending on the 
type of activity between 50-90% of the force endured by the knee joint is distributed by this area 
of the cartilaginous tissue. This distribution is primarily performed in the flexion phase where 
90% of the load is transmitted, while with a 50% distribution is exhibited in knee extension, 
which is because much of the meniscus action is in response to compressive forces (Aagaard et 
al., 1999). As recognized in common meniscal injury types, tensile “hoop stress” strength is the 
result of the expose to weight bearing loads that, if compromised, leads to serious degrading 
tears. Split into two phases, this loading response consists of first an initial mechanical reaction 
where the proteoglycan-collagen network, along with interstitial fluids, compress to increase 
hydrostatic pressure. The second phase is referred to as fluid extrusion, where this interstitial 
fluid flows from the fiber matrix, thus decreasing the hydrostatic pressure and resulting in stress 
relaxation across the meniscus. 
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Additionally, as alluded to in the above function, the meniscus assists in joint lubrication. 
This is expressed when the joint experiences a load as the synovial (interstitial) fluid is released 
to ensure low frictional forces in the articular cartilage. And finally, the stability of a healthy 
knee is due in part to the meniscus by deepening the tibial socket, which inhibits femoral 
translation on the tibia by increasing contact with the femoral condyles (Dept. of Rehabilitation 
Services, 2007). 
2.2. Types of Meniscal Injuries & Risk Levels 
As the most prevalent pathology of the knee, the desire for meniscal tear treatments is a 
global need. There are five varieties of tears, each with ranging levels of risk. 
Market Need 
Approximately ~60% of people over the age of 65 will experience a form of degenerative 
meniscal tear at some point in their lifetime and of this population, 38% will exhibit 
complications from current treatment methods. A particularly challenging aspect is working with 
the avascular sections of the meniscus, which causes severe deficiencies in the production of 
effective regeneration and replacement of the damaged tissue. This means that almost 2 in 5 
individuals that undergo treatment will not regain full mobility (Mordecai, 2014). Of the current 
treatments both in practice and in the pipeline, some show promising preliminary results, which 
will be discussed in detail later, but as of now, there is no “gold standard” for the treatment of 
meniscal tears. The current market for meniscus repairs, replacements and treatment is estimated 
at approximately $4 billion (Frizziero et al., 2012). 
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Horizontal  
Horizontal cleavage tears are more representative of older individuals. These consist of 
tears extending outward from the free margin to the intrameniscal substance where myxoid 
degeneration can occur. By dividing the meniscus into superior and inferior flaps, horizontal 
tears result in instabilities across different regions. This type of tear is a more frequent injury 
pattern and is caused by twisting exercises and extreme flexion of the knee joint. As such, this 
type of tear is often associated with athletes competing in martial arts and basketball, in addition 
to the over 40 population. 
Longitudinal  
A vertical or longitudinal injury is characterized by a tear parallel to the circumferential 
fibers of the meniscus and is referred to as a bucket-handle tear if severe enough, which can 
either remain attached by the anterior or posterior segment of the meniscus. This tear can results 
in true locking of the knee due to physiological shifts in the intercondylar notch. 
Radial  
Radial tears occur outwards from the free to periphery regions of the meniscus, where it 
can diminish the meniscal capacity of hoop stress-distribution through transection of the cartilage 
tissue. Due to the severe consequences of such a tear a total meniscectomy surgery is required 
for repair. 
Oblique  
Oblique tears, also known as “parrot-beak tears”, are also fairly common which results in 
mechanically unstable flaps and requires re-sectioning of the meniscal tissue to avoid tear 
propagation. If not addressed these flaps can interfere with knee flexion and are associated with 
osteoarthritis. 
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Complex 
Complete degenerative tears typically occur in older patients or from extreme overuse, 
associated with the onset of osteoarthritis. These tears occur in various regions of the meniscus 
based on the sections most deteriorated from repetitive motions, based on the individual patient’s 
activity levels and preferences. 
2.3. Treatment & Complications 
Patients with meniscal injuries have a variety of treatment options that are currently 
available to them depending on the severity/type of injury (Markis et al., 2012). The current 
options for treating meniscal tears include the following: physical therapy, partial meniscectomy, 
complete meniscectomy, surgical repair, or transplantation. The list below explains when each 
treatment option is used and what the complications are with each treatment option. 
Physical Therapy 
This treatment option is a non-invasive procedure that does not involve any form of 
surgery to treat the meniscal tear. Physical therapy is completed in conjunction with much 
resting and icing of the knee, along with applying compression to the knee and elevating it 
during the rest period. The downside to physical therapy is that it is only applicable as the main 
treatment option for minor meniscal tears. With physical therapy, the knee joint is strengthened 
back to its normal capacity; however, the small tear is sometimes never fully repaired if the tear 
is in an avascular region of the meniscus. Other complications include the pain and inflammation 
that is a product of this treatment option. This type of treatment is often only associated with 
tears in the vascular region of the meniscus known as the red region. 
22 
 
Partial Meniscectomy 
This treatment option is a surgical procedure performed on patients who have torn a 
portion of their meniscus in the avascular region, called the white region. This procedure is often 
chosen when the tear is classified as moderate or severe. A partial meniscectomy is when a 
portion of the meniscus is removed. Through surgical procedures, the surgeon will remove the 
damaged portion of the knee meniscus. Any procedure that removes a portion of the meniscus 
causes imbalances of loading within the knee and often leads to osteoarthritis. The load 
distribution is increased by an average of 235-335% for this type of surgery. 
Complete Meniscectomy 
This treatment option is also a surgical procedure that is most often performed on patients 
who have torn a portion of their meniscus known as the white zone. A complete removal of the 
meniscus is not as common as other procedures; however, it is used for severe or moderate tears 
to the meniscus to relieve pain and poor functionality. This procedure is an invasive procedure 
where the surgeon removes the entire meniscus. This treatment option has similar complications 
as the partial meniscectomy except these complications are amplified. The knee load distribution 
is increased by over 335% and the lack of a complete meniscus increases the chances of 
osteoarthritis due to no lubrication and cushioning between the tibia and femur. Postoperative 
complications can also include infection, chronic pain, or even bleeding or clotting within the 
joint. 
Surgical Repair 
Surgical repair is a treatment method used to repair the red region of the meniscus. The 
red region of the knee, being the vascular region of the knee, has a better ability to heal than the 
avascular regions of the knee. With tears or lesions in the vascular region of the meniscus, 
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surgeons can use sutures and stitching to repair the tear and allow for a natural healing process in 
the body. Unlike physical therapy, this type of treatment is performed on tears of the meniscus to 
the red region that are categorized as moderate to severe. Complications of this surgery are an 
extended healing time, inflammation and pain, as well as an increased need for re-surgery. 
Transplantation 
Knee meniscus transplantation is another treatment method for moderate to severe 
meniscal tears that occur in the white region of the meniscus. This procedure includes a complete 
meniscectomy of the damaged meniscus and then an implanted meniscus from a cadaver. A 
major challenge associated with this procedure is that there are very limited resources for the use 
of transplantation. Also, the transplants used for meniscal transplantation often have sizing issues 
and are not patient specific, which causes complications with load bearing. There is also a small 
risk of a patient receiving an infection due to the donor implant. 
Through each of these different treatment options that are currently available for patients, 
there are specific complications associated with each treatment option as seen above. There are 
general complications with meniscal tears as well that are seen with all types of treatment 
options. With surgical operations on the knee to treat meniscal tears, 38% of people have 
complications with these surgeries and are in need of re-surgery. As previously mentioned, with 
the implant of a new meniscus or surgical procedures on the damaged meniscus, the functional 
load bearing properties of the knee are altered. With the absence of a meniscus or part of a 
meniscus the articular cartilage is worn down overtime leading to joint stiffness, high levels of 
pain, and the chance of having osteoarthritis. Lastly, all of these procedures have long recovery 
times that can last up to a year in time. 
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2.4. Meniscus Anatomy 
The meniscus is a two-part component of the knee. There is a lateral meniscus and a 
medial meniscus that act as significant functional components of the knee. The image below 
gives a visual of how each portion of the meniscus is oriented in the knee joint (Figure 2): 
 
Figure 2: Meniscus shape/location 
(Caronia et al., 2013) 
The lateral meniscus is more circular in shape but smaller in size. The medial meniscus is 
more of a c-shaped construct in the knee that is slightly larger than the lateral meniscus. The 
lateral meniscus provides more mobility within the knee and covers a larger portion of the tibial 
plateau. It also bears 100% of the load transmission in the knee when the knee is in full flexion. 
The lateral meniscus covers 75-93% of the tibial plateau laterally while the medial meniscus 
covers 51-74% of the tibial plateau medially (Śmigielski, 2015). The table below shows various 
dimensions of the knee meniscus: 
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Table 1: Meniscal Dimensions 
 (Calvao et al., 2015) 
Each portion of the meniscus is composed of two different regions, an inner region and 
an outer region. The inner region of the meniscus is the white region and is composed of mainly 
chondrocyte cells. The white region is avascular and aneural as it receives little to no blood 
supply. The white/inner region of the meniscus is composed of 70% collagen dry weight; 60% of 
it is collagen type II and 40% collagen type I. The outer region of the meniscus is the red region 
and is composed of fibroblast-like cells. This region is more vascular than the inner region of the 
meniscus and is 80% dry weight of collagen type I (Fox et al., 2015). The image below displays 
the different regions of the meniscus (Figure 3): 
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Figure 3: Meniscal regions 
(Markis et al., 2012) 
The knee meniscus is composed of 72% water and 28% organic material. The organic 
material is composed of 75% collagen, 17% glycosaminoglycans (GAGs), 2% DNA, 1% 
adhesion glycoproteins, and 1% elastin. The knee meniscus performs many of its functions such 
as tension, shear, and compressive strength, load bearing and transmission, as well as shock 
absorption due to the alignment of fibers within the meniscus. The fiber alignment provides 
much of the structural integrity of the meniscus itself (Markis et al., 2012). The meniscus is a 
multi-layered construct within the knee that is composed of circumferential fibers (curved), and 
radial fibers (perpendicular to circumferential fibers). Throughout the inner and outer region of 
the meniscus are the circumferential fibers. The radial fibers are found throughout these regions 
as well. Mesh network fibers can be found more towards the surface of the meniscus. The two 
images below give a visual as to how the fibers are oriented in the meniscus (Figure 4): 
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Figure 4: Meniscal fiber orientation 
Left: (McHenry, 2005); Right: (Saliman, 2012) 
2.5. Universal Relevance 
To fully understand the possible expansion into broader research realms surrounding our 
28-week project, we took a step back from the in depth, technical research to evaluate where our 
study fits in the tissue engineering field. This analysis of relevance helped to give us perspective 
into the gravity of any advances in our field that may arise as a result of this project.  
Informed Project Intent 
The ultimate intent of our research on meniscal injuries is to discover successful methods 
of replacing damaged menisci with naturally grown, healthy meniscus constructs. This involves 
the utilization of biocompatible, bioactive scaffolding materials to act as the backbone for tissue 
growth of which they are products in development and undergoing approval processes for 
commercial use. But as our research on synthetic and artificial implants has shown, there is an 
inherent need for novel scaffolding techniques to develop long-lasting and safe replacement 
menisci. The drawbacks of these non-natural implant techniques are discussed later in detail but 
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the major takeaway is that these acellular scaffolds are unable to facilitate the necessary nutrient 
perfusion for both the regeneration and maintenance of the meniscal connective tissue. 
Project Expectations and Applicability 
The expectation of this project is to prove multiple cell alignments within the same tissue 
construct are possible, modeling the circumferential and radial fiber alignments in the native 
meniscus. The importance of this novel aspect cannot be understated, as no methods currently 
exist to produce custom fiber alignments that display the necessary mechanical properties for this 
implementation for a target tissue. By using cells to validate our techniques, our construct is 
expected to handle the nutrient perfusion that is critical for cell functioning and viability. Also in 
expanding past the unnatural environment of 2D cell cultures into the field of representative 3D 
cultures, we will be able to create a basis for 3D living tissue research. Through an understanding 
of the culture microenvironments and their direct influence on extracellular matrix component 
(ECM) production and the requisite cell properties, there is viability to create a universally 
advantageous tissue scaffold for many relevant scaffolding studies. 
2.6. Tissue Engineering Strategies 
In the context of this project, the tissue engineering approach envisaged here involves the 
development of a biomorphic scaffold that is able to provide relevant biochemical signals to 
chondrocyte cells to restore and regrow tissue functionality. It is important to have a system that 
supports cell life and allows the cells to keep their phenotype. The scaffold should allow cells to 
grow, align and differentiate in a way that mimics the native tissue. Biochemical factors may be 
added to aid in cell growth and functionality. 
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Nutrient Perfusion 
Nutrients in the body can only diffuse up to 100-200 μm (Jain and Carmeliet, 2000). 
Because of this, most cells are located within this distance from a capillary. However, cartilage is 
an avascular tissue, meaning there is a lack of blood vessels. Necrosis can occur within hours 
with improper flow of nutrients in and waste out (Miller, 2014). Because of this, there needs to 
be a method of perfusing nutrients through the tissue.  
Flow perfusion bioreactors are often used to get nutrients throughout the scaffold. 
Dynamic perfusion bioreactors can also stimulate the tissue (Jaasma et al., 2008). These systems 
are normally used with porous scaffolds. As long as the porosity is high enough, and the pores 
are interconnected, this provides a system that can allow for nutrient perfusion.  
Cellular Scaffold 
Cells are the living, active part of an engineered tissue. Chondrocytes are the cells that 
make up the meniscus, and are necessary for meniscus function. 
Chondrocytes 
Chondrocytes are essential for meniscal function as they produce, maintain, and remodel 
the cartilaginous ECM (Chung et al., 2008). Chondrocytes are terminally differentiated cells that 
do not proliferate. This means that progenitor cells will need to be cultured to the desired cell 
density before differentiation. The differentiation pathway starts with MSC’s which are 
differentiated into chondroblasts which can then be differentiated to chondrocytes.  
For clinical purposes, normally autologous chondrocytes would be isolated, expanded, 
and seeded for engineered cartilage tissue (Chung et al., 2008). However, human progenitor cells 
are very limited in their abilities. The ATDC5 immortalized mouse chondrogenic cell line is an 
acceptable research model for cartilage tissue once differentiated (Tare et al., 2005). . These cells 
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can be cultured and expanded to get the desired number of cells, then differentiated using insulin 
and ascorbic acid (Negishi et al., 2001). 
ATDC5 Culturing 
ATDC5 cells are typically cultured in an incubator at 37ºC, 5% CO2, and 70% humidity. 
The culture media used with these cells is composed of Dulbecco’s Modified Eagle Medium 
(DMEM) without L-Glutamine, with pH indicator phenol red and 4.5 g/L glucose and sodium 
pyruvate in a 1:1 ratio with Ham’s F12. The media is also composed of 1X Glutamax, 1X 
Penicillin Streptomycin, and 5% fetal bovine serum (FBS).  
Three Dimensional Tissue 
The easiest way to culture cells is in a two dimensional environment. However, tissues in 
the body are three dimensional in geometry. In order to mimic the natural tissue better, there are 
ways of creating three-dimensional tissues, mainly with scaffolds and hydrogels. 
Scaffolds 
Scaffolds in tissue engineering provide the structure and shape for the cells to grow on. 
Scaffolds provide the mechanical strength until the cells and ECM grow and gain sufficient 
strength on their own. It is important for scaffolds to degrade at a rate that mirrors cellular/ECM 
growth so that isomorphous tissue regeneration can occur. Figure 5 below shows the idea of 
isomorphous tissue regeneration.  
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Figure 5: Isomorphous Tissue Regeneration 
 
There are many ways of creating a scaffold. The main ways porous scaffolds can be 
created by freeze drying, solvent casting/porogen leaching; melt molding/porogen leaching, and 
gas foaming. However, these methods cannot have alignment in the pores, except for in freeze-
drying. In this method, the pore alignment cannot be very closely controlled, and the pores are all 
in one direction.  
Electrospinning is a technique used to create a fibrous scaffold, which is very attractive 
due to the extremely high surface area to volume ratio that it produces. A high surface area to 
volume ratio means that more cells can be seeded more densely on the scaffold. Electrospinning 
also allows for high control of the fibers diameter and some control of fiber arrangement. 
However, as highlighted later in this chapter, there is a large gap in knowledge and technology 
for fiber arrangement. There are no methods that can currently give a curved aligned fibrous 
scaffold.  
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Hydrogels 
Hydrogels in the simplest terms are polymer gels in which water makes up the liquid 
component. Hydrogels have been used a lot recently for three dimensional cell suspension. The 
rate of crosslinking and final stiffness need to be considered when deciding on which hydrogel to 
use. The rate of crosslinking is how quickly the hydrogel can go from liquid to gel form. If this 
process takes too long, the cells, which are denser than the liquid, will sink causing an uneven 
distribution of cells. Generally, if the hydrogel crosslinking occurs within 2-3 minutes the cells 
will remain evenly distributed. The final stiffness is important for many reasons. First, this will 
provide the mechanical strength for the combination. Also, cells react to the environment around 
them. Many studies have been performed showing that the stiffness of the cellular environment 
affects cellular differentiation and phenotype.  
Hydrogels do not normally have a nutrient perfusion pathway. This pathway must be 
created if gels thicker than 100-200 μm want to be created, which is more realistic to most 
tissues in the body. Hydrogels also do not offer any guidance to cellular arrangement. This is a 
major downside to hydrogels, as every tissue has a specific arrangement of cells and ECM.  
2.7. Current State of the Art 
Removing the damaged portion of the meniscus without replacing the tissue is the current 
accepted medical practice (Fox et al., 2015). To address this limitation, meniscus implants are 
being produced from tissue scaffolds. Without a standard scaffold available on the market, there 
are many varieties. Implants can be designed for total or partial meniscal replacements. The 
scaffolds are fabricated out of natural or synthetic materials (Zheng, Z. et al., 2015). 
Macromolecules from the natural extracellular matrix from the meniscus would provide an ideal 
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environment for tissue engineering. Such molecules would be collagen and glycosaminoglycans 
(GAGs).  
There are many cartilage tissue scaffolds that are available commercially. Most scaffolds 
are similar in design. A major design consideration for a meniscal scaffold is that mature 
chondrocytes do not proliferate (Bahcecioglu, G. et al., 2014). Therefore, scaffolds must be 
made to allow for progenitor cells to be cultured to the correct density before differentiation is 
induced.  
The overarching drawback of the current scaffolds is the lack of alignment in the fibers to 
guide cell growth. A scaffold for the meniscus needs a system that will replicate the collagen 
fibers and GAG deposits in the superficial and sub-chondral zones.  
Collagen Matrix 
One approach to creating an implant for replacement is using a collagen matrix (Zheng, 
Z. et al., 2015). Collagen meniscus implants can contain Collagen I, Collagen II, or a mixture of 
both. A scaffold of Collagen I and GAG provides more strength while Collagen II and GAGs 
increase the rate of cell proliferation and lubrication. Even with natural materials, there are 
difficulties with cells interacting to form a meniscus matrix and forming biometric meniscus 
shape. The degradation of the scaffold and suturing to the native tissue are also drawbacks. 
 One example of a collagen meniscus replacement implant was RenGen’s Menaflex (Fox 
et al., 2015). This was a scaffold of purified Collagen I from a bovine Achilles tendon. Similar to 
a surgical mesh, Menaflex was approved by the FDA to repair and reinforce the medial 
meniscus. The scaffold could be trimmed to fit the damaged site and then be sutured to the 
remaining healthy tissue. Over time, the patient’s cells would grow into the scaffold. This 
procedure was considered an alternative to a partial meniscectomy. The Menaflex was successful 
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in the amount of cellular integration into the implanted matrix and that the material composition 
allowed it to be resorbed into the body. 
Along with advantages, there were disadvantages with the Menaflex design and 
validation (Fox et al., 2015). Two design drawbacks were that the scaffold was not made from 
living tissue and that it shrank in size over time. After implantation, patients with Menaflex were 
required to restrict their activity level for up to six months. A partial meniscectomy, a procedure 
the FDA considered of the same caliber, restricted the activity level of patients for three weeks. 
Menaflex was unsuccessful for complete meniscus replacement and could not be used for lateral 
meniscus repair. The FDA retracted its approval of RenGen’s Menaflex due to the company’s 
inability to prove the benefit of the product for patients through proper clinical trials and 
validation.  
Actifit 
Another approach is the Actifit scaffold (Zheng, Z. et al., 2015). The design is a highly 
interconnected porous matrix of synthetic polyurethane. It has been tested for chronic meniscal 
tears but not full replacements. Actifit has shown success for smaller repairs with minimal need 
for activity restrictions. The architectural structure allows the tissue to grow into the large pores 
at the edges of the scaffold after three months. The synthetic make up allows for flexibility of 
material composition, and consequently the material properties such as degradation time. The 
Actifit scaffold is 80% biodegradable polymer and 20% polyurethane.  
Currently, Actifit is suitable for lateral meniscal repairs in Europe (Zheng, Z. et al., 
2015). It has not been approved in the United States for implantation. Actifit is not considered to 
be a long-term solution for repair due to a lack of data. Long-term studies need to be conducted 
since the short term relief of the scaffold may not outweigh unseen risks of prolonged exposure.  
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Mimetix 
The Mimetix scaffold is one company’s version of a cartilage tissue scaffold (Amsbio 
2013). The scaffold is constructed out of electrospun polymer poly (L-lactide) microfibers. The 
medical grade PLLA has a porosity of 80% with consistent pore size and fiber diameters. The 
fibers can be customized with different coatings and can be purchased in 12, 96, or 364 well 
plates. The scaffold can grow successfully grow cells in a 3D environment. The electrospun 
fibers are extruded out of a single needle system and utilize a rotating drum for a collection 
system.  
Using PLLA as the scaffold material, Mimetix is not biodegradable (Amsbio, 2013). The 
electrospun fibers have a random orientation that is not cohesive to mimicking the anatomy of 
the meniscus. The scaffold needs to be preconditioned before cell seeding and has only been 
used in conjunction with human primary, cancer, and stem cells.  
Electrospinning 
One method of fiber scaffold deposition is using an electrospinning machine 
(Yousefzadeh M. et al., 2012). The current models create nanofibers, which is an appropriate 
size to overcome the natural perfusion limit. Fiber alignment can be random or parallel, 
depending on the machine. There is no established design for electrospinning machines and there 
are many possible modifications to create fibers with alignment. The main two categories for 
modifications include externally applied forces and collection plate design.  
Electrospinning requires charging the fiber material that is being extruded (Li et al., 
2005). Some designs take advantage of this and create charged electrodes or plates to guide fiber 
deposition. One popular design is to have a pair of parallel plates surrounding the extruder. Both 
plates have an equal charge, the same of the fiber material. When the fiber is extruded, both 
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plates repel it. The fiber travels in a straight line and is deposited on the collection plate. The 
fibers can also be guided by charged electrode that repel the fibers to keep them straight or of the 
same charge to attract them to align parallel on the plate. The electrodes can be as simple as a 
charged copper wire running along the backside of the collection plate (Yousefzadeh M. et al., 
2012).  
Modifications can be made to the collection plate, another part of the electrospinning 
machine (Li et al., 2005). There are numerous approaches to collecting the fibers. The original 
design is a flat collection plate than randomly aligned fibers were ejected onto. A rotating drum 
can be placed at the back of the collection plate to pull the fibers tight and wrap them around the 
drum like thread around a spool to create aligned fibers (Yousefzadeh M. et al, 2012). The 
collection plate can move to create alignments but the plate must be moving as fast as the 
injection speed to avoid fiber breakage.  
One specific electrospinning collection design brought collection plate modification and 
electric field manipulation together (Zhang, K. et al., 2009). Electrospun PLLA was deposited on 
a collection plate of charged needles. The needles extruded from the plate in a square formation, 
as seen below, while the remaining portions of the plate were insulated (Figure 6).  
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Figure 6: Collection plate design from literature study 
(Zhang, K. et al., 2009) 
During collection, the PLLA self-assembled into high-density fiber areas at the top of the 
charged needles while the bottoms of the needles and plate yielded low fiber density. The 
advantage of this collection plate system is the ability to create shapes from electrospun fibers. 
The main drawbacks of this system were the fibers were spun at a micro-scale rather than the 
nanoscale and were deposited at the tops of the needles. This collection plate could not create a 
thick layer of threads, as would be possible if the threads deposited at the needle bases and 
extended to the tips.  
Overall, the current electrospinning technology lacks the ability to create a curved fiber 
scaffold to create cell alignment as seen in natural meniscuses.  
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3. PROJECT STRATEGY 
This chapter provides a description of how our projects client statement, objectives, and 
constraints were developed.  
3.1. Initial Client Statement/Revised Client Statement 
The knee meniscus is a two-part three-dimensional structure that provides shock 
absorption, stability and lubrication to the knee. Meniscal tears and ruptures of the knee are 
very common injuries. The team will engineer a three-dimensional, biomorphic tissue scaffold 
to research the ability to grow, ex vivo, replacement menisci. This scaffold will be printed with 
a commodity 3-D printer modified and re-engineered as necessary by the team to provide higher 
resolution. 
Once our advisor, Professor Ambady supplied us with his initial client statement above, 
the team set to work conducting background research on the meniscus and learned the 
capabilities of our available methods for growing 3-D tissue models. 
3.2. Technical Design Requirements 
The team developed a list of objectives, secondary objectives, functions and means, 
project constraints, and device constraints to guide in the maturation of the project, 
Objectives 
The team compiled a list of objectives that were most critical for this design to achieve: 
safe, customizable, user friendly, compatible, reproducible. Each objective is discussed in detail 
below, with an explanation of its ranking and the corresponding secondary objectives. 
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Safe 
This product must be safe for all stakeholders, including the designers, patients, medical 
professionals, and manufacturers. Safety is an objective that encompasses all of the stakeholders 
involved. Without this product being safe for each of the stakeholders, it will not be possible to 
patent this device for use. If a product puts a stakeholder at any risk of physical harm, then it will 
not be considered a beneficial product. Therefore, safety is an important objective that this 
product must satisfy. This product being safe can be broken down further into secondary 
objectives: 
1. Biocompatible: This product must be biocompatible to avoid a foreign body response 
when it is implanted into a patient. The material considerations must all be considered 
biocompatible. The interaction between the product and the body/surrounding tissue must 
not cause inflammation or a toxic response. If the material is rejected from the body or 
broken down within the body, it will not be able to perform its primary function. This is 
the most significant secondary objective beneath safety because the main function of this 
product will be to exist in the body and function as normal knee meniscus would. If this 
product is not biocompatible, the main function of the device will no longer exist.  
2. Sterile: The product must be able to be sterilized prior to implantation to avoid the 
contamination. The product will not be biocompatible if it cannot be sterilized before 
being implanted into the body. Therefore, this secondary step is essential in achieving 
safety for this product, which is why it is ranked second behind biocompatibility.  
3. Implantable: This device must also be implantable and safe to handle by medical 
professionals. The procedure of implanting the product must not jeopardize the safety of 
the patient or surgeon/medical professional in any way. This secondary objective is 
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important in the consideration of both the patient and medical professional. It is vital that 
there is a reliable procedure for implanting a biocompatible meniscus replacement 
without risking the sterility of the product. This procedure must also be safe for the 
medical professional. For these reasons, this is why implantable ranks third among the 
secondary objectives for safety.  
4. Manufacturability: The product must also be safe to manufacture. The procedure to create 
this product must not be unsafe to the designers and manufacturers. Also, the materials 
that are being handled must be safe for human handling. The major function of this 
device is to provide a patient with a functional meniscus replacement, however, it is still 
important for the product to be developed without posing health risks to the designers and 
manufacturers. Therefore, manufacturability safety is an important objective to be 
considered after meeting the objectives listed above.  
5. Meet FDA Regulations: When the product is ready to be used clinically, it must meet 
FDA Regulations in order to allow secondary sources to use the product in practice. If the 
FDA does not approve the product it will not be able to be used for any medical 
applications. If the secondary objectives for safety are satisfied then the product should 
pass FDA approval, which is why the FDA approval is the lowest priority secondary 
objective for the safety of the product.  
Customizable 
It is essential that the device is designed in a way that can be customized in the future. 
This is important for implantation, so that the scaffold can be patient specific. Each patient has a 
meniscus with specific morphology that helps provide all the proper functionality. Therefore, it 
is important that this product have the ability to be customized to help provide the full 
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functionality of a meniscal implant to each patient. Below are the secondary objectives for 
customizable: 
1. Cell alignment control: The control of cell and fiber alignment is an important and novel 
aspect of this project. All people have the same general fiber orientation in their 
meniscus. It is important that the specific size, length, and orientation of the fibers is 
achieved to help allow for these scaffolds to be customizable for each patient. Cell and 
fiber alignment is a major focus for this project, which is why it is the most important 
secondary objective beneath customizable. This can be achieved through using an 
electrospinning technology to customize the fibers that are developed for the scaffold. 
2. Design any shape: The control over scaffold shape and morphology is also very 
important to the customizability of a replacement meniscus. The ability to control the 
shape of the scaffold is a key aspect of making each scaffold patient specific. This can be 
done with a combination of techniques. The first technique would be to use computer 
aided design to mimic the meniscus of a patient from MRI images. Creating that specific 
shape could then be complete through 3D printing or electrospinning. This is ranked 
second behind cell alignment because it is not the main aspect of this project but is still 
very important for making each scaffold patient specific.  
3. Cell differentiation control: The use of IPCs allows for the differentiation into the cells of 
the patient. This is important for the use of this product in the long run. For this project, it 
is not as vital that patient specific cells are developed but it is recognized that this is 
important for the customizability of the product in the future.  
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User Friendly 
This product must be easy to use for the stakeholders who are directly working with it. If 
the device is challenging to work with for stakeholders, it will inhibit the ability for the product 
to be used properly and function properly. The secondary objectives for ease of use are as 
follows: 
1. Researchers: The product must also be easy for researchers to use and test to accurately 
determine the functionality, strengths, and weaknesses of the device. Our main focus is 
for this project to be used for further research in developing a meniscal implant with 
proper fiber alignment. Therefore, this secondary objective is most important for the ease 
of use objective.  
2. Medical Professionals: This device must be easy for surgeons, doctors, and medical 
professionals to use when conducting a procedure on a patient to ensure proper 
implantation and functionality. The end goal is for this product to be used in clinical 
practice but not before further research is conducted, which is why it ranks behind the 
researchers.  
Compatible 
This product needs to be compatible in a couple different ways. If the product cannot 
cohesively fill the current needs, than it will not work as proof of concept or research tool. 
1. Proper materials: The product must have the proper materials necessary for function. The 
materials of the design be manufactured as well as having a product that is 
biocompatible.  
2. Different lab set-ups: The main user of this product is thought to be researchers. The 
design must integrate into current lab equipment and protocols. If the base clientele can 
43 
 
use a product without requiring a lot of additional expenses, the product will be more 
successful. 
Reproducible  
Reproducibility is important for proof of concept since it is the objective meaning that all 
results from the project need to be able to be repeated by others. All aspects of the project need 
to be able to be reproduced, from the manufacturing process to experimental procedures. 
1. Manufacturability: The design must be able to be manufactured, for the project and in the 
future. Relating to the project, the design must be made out of resources readily available 
to the team or available for purchase. The design should incorporate standard 
measurements for easier machining. Manufacturing standards should be taken into 
account. 
2. Design Validation: The design and product should be validated to truly be a proof of 
concept. All validation should be able to be repeated.  The design needs to create similar 
results to be a dependable research tool.  
 
Figure 7: Objective tree diagram with objectives and sub objectives  
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The team ranked the objectives and each were then compared to each other and priorities were 
determined. 
Pairwise Comparison Chart 
 Safe User 
Friendly 
Easily 
Manufacturable  
Customizable Compatible Sum 
Safe X 1 1 0 0 2 
User Friendly 0 X 0.5 0 0 0.5 
Reproducible 0 0.5 X 0 0 0.5 
Customizable 1 1 1 X 0.5 3.5 
Compatible 1 1 1 0.5 X 3.5 
Table 2: Pairwise Comparison Chart 
 
From these rankings, customizable and compatibility were determined to be the highest 
priority. This is because for compatible, the device must be biocompatible and support cell life. 
Equally important, the scaffold needed to be customizable to mimic varying tissue structures in 
the body. The next most important objective is that the device must be safe. The next two 
objectives are that the device must be user friendly and reproducible. Reproducibility is 
important for proof of concept. Lastly, the device must be easy to use so that researchers won’t 
have to invest too much. 
Functions and Means 
The team compiled a list of functions that were most critical for this design to achieve: 
safe, user friendly, manufacturable, customizable, compatible. Each function and corresponding 
means is discussed in detail below, with an explanation of which means were chosen as a design 
solution. Table 3 illustrates the design functions and means. 
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Function Means   
Scaffold Creation 3D Printing Electrospinning  
Fiber Collection Pin Matrix Plate Magnets Rotating Drum 
Customizable 
Orientations  
Soldered Rows Weaved Wire Brass Caps 
Fiber Removal  Forceps Parafilm Fine Comb 
Table 3: Function and means chart with chosen mean in bold 
Scaffold Creation 
The team was tasked with creating a three-dimensional tissue scaffold. This was the first 
function of the design that needed to be addressed and arguably the most important since the 
chosen mean influenced the rest of the functions for the design. There were two means available 
to the team. 
1. 3D printing: The 3D printer available could print SolidWorks designs to a resolution of 
+-0.10mm with a precision of 11 microns. These were limiting factors for how precise a 
scaffold could be printed. In addition, the printer could only print two materials; 
polyvinyl alcohol (PVA) and polylactic acid (PLA).  PVA is a biocompatible material 
that cells can adhere to. However, it degrades quickly and swells when exposed to cell 
media. 
2. Electrospinning: The electrospinning machine in the Jain lab was a means available to the 
team. The three main components of the machine, the voltage source, syringe pump, and 
syringe tip, could be interchanged or adjusted. The voltage source could supply over 
30kV of charge. The syringe pump flow rate was adjustable and syringe tips of different 
diameters were available. The electrospinning machine could be used with any polymer 
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that would dissolve in water or organic solvent. Lastly, the electrospinning process could 
create random fibers with nanometer diameters. 
The team used the means of electrospinning due to the higher number of material choices 
and the smaller fiber diameter. The problem to overcome with electrospinning was the random 
fiber generation. 
Fiber Collection 
The next function of the design involved the need of controlling how the nanofibers 
aligned. Randomly aligned fibers do not mimic native tissue. Our design needed to control how 
the nanofibers aligned so the 3D scaffold better represented tissues in the body. 
1. Pin Matrix Plate: A pin matrix plate collects charged nanofibers on the tips of grounded 
metallic needles. A collection plate with only specific needles or rows of needles 
grounded may control fiber alignment. This would require a very fine pin matrix to 
achieve curvature at the nano-level. 
2. Magnets: Magnets with polar charges may be placed on either side of the syringe tip. 
When the polymer extruded down from the tip, it would create varying degrees of 
straight and curved fibers depending on the proximity to the magnets. This method would 
have less control on fiber orientation. 
3. Rotating Drum: The fibers can be extruded onto a flat collection plate randomly aligned. 
The fibers are then pulled onto a rotating drum to become aligned in a curved fashion. 
This would require very small drums to achieve curvature at the nano-level.  
The team decided on using the pin matrix collection plate to fulfill the function of 
collecting nanofibers. 
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Customizable Orientations 
To further the versatility of the design and scaffold, the team investigated different means 
to customize fiber alignment. 
1. Soldered rows: The bottom of the metallic pin matrix could be soldered together to form 
the alignment desired by the user. This was a permanent solution for grounding the pins. 
The user would need another collection plate to create an alternative fiber alignment. 
2. Weaved wire: The backs of the pins could be attached with wire. This would not be a 
permanent solution but it would be difficult to form a wire to a fine pin matrix without 
accidentally charging pins outside the desired alignment. 
3. Brass Caps: Brass caps could connect the backs of the metallic pins to the voltage source 
through wires. The alignment could be altered by the user and would only charge the 
desired pins.  
The team went with using the brass caps to customize the fiber collection due to the 
accuracy and ease of use of the design. 
Fiber Removal 
The nanofibers need to be removed from the collection plate after electrospinning. The 
fibers are very delicate. Moving or tugging on the fibers can warp or destroy the customized 
alignment. The team thought of three means to remove fibers and maintain integrity. 
1. Forceps: One means of removing the fibers could be with forceps. The fibers could 
collect onto the pin tips and then carefully removing with forceps. The fibers could 
possibly stick to the needle tips and lose the alignment. The fibers could be taken off the 
collection plate and then placed into a petri dish. 
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2. Parafilm: Parafilm could be placed on the needle tips of the collection plate and then 
fibers could collect onto the parafilm. The removal of parafilm from the plate would be 
easier but would add another step into the fiber removal process. The fibers would need 
to come off the parafilm before being placed into the petri dish due to the toxicity of the 
parafilm to cell culture. 
3. Fine Comb: The fibers could collect directly onto the needles of the collection plate. A 
fine comb could be slipped into the pin matrix and drawn up to collect the fibers. This 
would require an extra tool to be manufactured to the fine dimensions of the needles and 
would add an extra step to the fiber removal process. The fibers would need to be 
removed from the comb before being placed on a petri dish.  
The team chose to remove the fibers with parafilm as the means of fiber removal. The 
parafilm was readily available and maintained most of the alignment of the scaffold. 
Specifications  
The team needed to make a collection plate that could withstand the operational ranges 
for electrospinning which can be found in Table 4. 
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Electrospinning Operation Range Description 
Voltage 10-30 kV higher voltage results in finer 
fibers and increased material 
strength 
Flow rate <0.5 mL/h Slow to allow organic solvent 
to evaporate- beading occurs 
at higher flow rates 
Needle to plate distance 10-20 cm less mechanical strength at a 
further distance, too close 
then solvent can't dissolve in 
time 
Polymer density 2-20 wt. % dissolved in water or organic 
solvent 
Fiber diameter 100-200 μm need fibers to be a smaller 
diameter than limit to allow 
tissue perfusion 
Table 4: Operational ranges for electrospinning 
 
The material of the collection plate needs to be able to withstand high voltages. The base 
must be a non-conductive material as to not attract charged fibers. The pin matrix must be 
conductive and able to pass voltages up to 30kV. The connective backing for the pins must be 
conductive with a high voltage capacity as well. 
Constraints 
The constraints were divided into two categories; project and device constraints. Project 
constraints are limitations due to the nature of the MQP and academic year. Device constraints 
address limitations of the product design that must be considered for a successful outcome. 
Project 
Cell proliferation and differentiation: The ATDC5 cell line requires proliferation and a 3-
week differentiation period in the scaffold. Time must be well managed since the academic year 
is 28 weeks long. The limited budget is also a project constraint. 
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Device 
The product needs to be designed within the WPI machine shop's capabilities. The 
machine shop was the team's sole source for manufacturing. An example would be that the 
diameter of the pins must match a drill size within the machine shop. The device must also 
eliminate electrical hazards for operators. 
3.3. Standard Design Requirements 
One standard applicable to the team's project was manufacturing standards for designs 
created in SolidWorks. All drawings needed to be made with the SolidWorks feature for drafting 
standards for ISO. The collection plate design, if mass manufactured, would need to comply with 
ISO's standards for dimensional specificity.  
Another industry standard applicable to the project involved cell seeding of the scaffold. 
The group needed to follow an industry approved methodology for counting cells in a high-
density cell suspension. This was required to ensure the accuracy of number of cells seeded on 
the scaffold met industry standards. The team used a C-chip disposable hemocytometer. The 
dimensions of the hemocytometer grid were 0.3mm x 0.3mm. The cell count was done by the 
user, counting cells in four of the nine counting squares. This process is the least accurate during 
low cell counts or high cell counts with clumping.  
The team also conducted a risk assessment for safety for the project. The findings of the 
assessment can be seen in Table 5. 
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Hazard Who can be 
harmed 
Potential 
injury or 
damage 
Risk 
Controls in 
place 
Risk 
Assessment 
Action to 
control risk 
Electrical 
Electrospinning 
Machine 
Operators Electrical  
shock 
Plastic 
barrier 
Moderate Voltage off 
until barrier 
is closed 
Pin Matrix 
collection plate 
Operators Puncture Carrying 
case 
Low Contain plate 
exposure 
time. 
Transfer 
from 
carrying case 
to machine 
and back. 
Chemicals Operators Inhalation of 
organic 
solvent, eye 
irritation 
Handle 
chemicals in 
hood, gloves, 
safety glasses 
Low Follow 
procedures 
closely 
Biohazard Operators Exposure to 
cells, 
chemicals 
Gloves, 
handle in 
culture hood 
Low Follow 
procedures 
closely 
Table 5: Risk Assessment for project 
 
The team identified and assessed various hazards in the project, determining all could be 
well managed by following procedures. 
3.4. Pathway to Revise Client Statement 
  From the initial client statement, we consistently modified it to what is now our current 
client statement: 
Meniscal tears and ruptures of the knee are very common injuries. The team will 
engineer a custom aligned 3D cartilage tissue scaffold to grow, ex vivo, replacement menisci. 
This client statement has been cut down to the basic client need and will likely be carried 
out with a combination of different construction techniques (electrospinning, 3D printing, etc.). 
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As it stands right now this client statement shows the ultimate deliverable within the scope of our 
project. 
In the process of conducting background research, our team began making gradual 
modifications to our client statement based on our findings. Our first revision was redefining our 
final deliverable. Originally our statement was geared towards a “three-dimensional, biomorphic 
tissue scaffold”, which would closely model the physical properties of the meniscus. The team 
believed that creating a universal tissue scaffold would be equally as effective in proving the 
effectiveness of seeding and growing cells in ex vivo conditions. Once this condition can be 
proven on a broad scale, the model can be specialized to form a family of products for specific 
tissue constructs. Through further research in the current “gold standard” technology, we 
determined that there were already viable ongoing scaffold experiments that focused on the 
seeding, proliferation and differentiation of cells on biocompatible materials. After a 
reevaluation of our project goals we determined that a new, novel component was necessary to 
make our project stand out. Initially we believed this novel idea was to focus on a bi-zonal 
scaffold, which would closely model a natural meniscus. However after sitting down with both 
Professor Ambady, we determined the novel aspect of our project is now focused on the ability 
to create multiple cell alignments within a single scaffold. This is what led us to develop the 
revised client statement that our group presented above. 
3.5. Project Approach  
The team expected to hit deadlines for each term involving research, electrospinning, 
prototype creation, and scaffold creation. Cell culture was an aspect of the project that needed to 
be carried out throughout the duration of the project. The team needed to follow and achieve 
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these milestones for a successful project. The success of scaffold seeding directly depended on 
creating a final design that could achieve fiber collection and alignment.  
A term was reserved for research to better the team's understanding of the project and 
how to find a solution. After conducting research, the team was able to create a revised client 
statement as well as set up objectives for the project. Overall, A term set up the team up to start 
prototyping and electrospinning the next term. 
The technical aspect of the project began in B term. The team needed to manufacture the 
first prototype so electrospinning with the team's design could begin by the end of the term. This 
would confirm that the pin matrix was a design that could lead into customized scaffold 
development in the next term from a final design.  
The final design needed to be determined by the beginning of C term. This would allow 
ample time for manufacturing of the collection plate as well as scaffold creation. Aligned 
scaffolds were created in this term to allow for cell seeding. The team wanted to observe cells on 
the scaffold for as long as possible to ensure design validation. To ensure the success of the 
yearlong project, the team created a Gantt chart that can be seen in the Appendix B. 
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4. DESIGN PROCESS 
The team followed the engineering design process as highlighted in this chapter. 
4.1. Needs Analysis  
The functions of the collection plate could be divided into two categories; needs and 
wants. Needs are requirements or results that the final design must meet or create to be a success. 
Wants are attributes that can further the success of the final design but are not necessary. Table 6 
illustrates the functional wants and needs of the project. 
 
Function Want Need 
Attract and Collect Fibers  X 
Create Scaffold  X 
Ability to create fibers in customized alignments  X 
Accept high amounts of voltage safely  X 
Compatible with different electrospinning machines  X 
Fiber removal with perfect alignment X  
Quick customization X  
Fiber diameters small enough for nutrient perfusion X  
Very fine pin matrix for increased alignment control X  
Table 6: The functional needs and wants for the project 
 
The needs analysis was done with the client in mind; researchers. The collection plate 
must be compatible with different electrospinning setups. Some machines use gravity or syringe 
pumps. The design needed to be compatible with as many setups to be more versatile and appeal 
to as many research labs as possible. The collection plate must not exceed the dimensions of 
plastic barriers surrounding the electrospinning machine or extend too close to the syringe tip. 
The collection plate needed to safely be charged up to 30kV to be used during electrospinning. 
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The plate needed to attract and collect fibers long enough to create a scaffold with layers of 
fibers, around 1mm thick after running the electrospinning machine for the average test time of 
20 minutes. To improve upon the electrospinning process, the fibers needed to be controlled so 
the fiber visually followed the alignment under 20X magnification. This alignment must be 
changed as the user desires.  The wants for the project are desired but are not critical for a proof 
of concept design. The function needs can be found in Table 7. 
Function Needs Mean Specification 
Attract and Collect Fibers Pin Matrix Metallic pins with 
diameter of drill 
bit in machine 
shop 
Create Scaffold Electrospinning Fiber diameter of 
500-600 μm 
Ability to create fibers in customized 
alignments 
Brass Caps Diameter slightly 
larger than pins 
Accept high amounts of voltage safely Metallic pins <30kV 
Compatible with different 
electrospinning machines 
Collection plate 
design 
<5x5x5 in 
Fiber removal Parafilm Slightly larger 
than dimensions 
of pin matrix un-
stretched 
Table 7: The function needs and the corresponding means and specifications 
 
4.2. Conceptual Designs 
One initial conceptual design was to use magnetic fields to control and change fiber 
alignments. Previously, magnetic fields have been used to create straight aligned fibers. This was 
done by a process shown in Figure 8, with the collecting fibers being spun into the "b" region of 
the magnetic field. The team’s conceptual design was to use the "c" region of the magnetic field 
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to create curved fibers. However, the team determined that this would allow for limited control, 
and very limited customization. Because of this, the team moved on to further design ideas.  
 
Figure 8: Magnetic Electrospinning (Yang et al., 2007) 
 
4.3. Preliminary (Alternative) Designs  
The team considered many alternative designs which are highlighted in this subchapter. 
Initial Soldered Pins 
Benefits 
 
The goal of this initial design was to act as a proof-of-concept, which we demonstrated 
by producing aligned fibers on a small-scale with successful reproducibility. In performing this 
soldering the team was able to ensure that all necessary pins were connected to eliminate a 
potential confounding variable if breakages in the alignment were to occur.  
Limitations 
 
As the associated soldering requires permanent fixation of charged orientations, meaning 
that new plates would have to be produced for each desired fiber alignment. We next 
experienced restrictions in sizing and pin number as the copper-plated pins used were 0.75 inch, 
14 gauge, leaving us with too few pins to create more complex orientations with the given 5x5 
57 
 
matrix. As the initial focus was on collection along each row, these pins were 5 mm apart 
whereas each row was separated by 6 mm, which could cause skewed results once we began 
developing angled shapes (Figure 9). 
 
 
Figure 9: Isometric and bottom views of Prototype 1 
 
Insulating Cover  
Benefits 
This design would allow only the exposed pins to have fibers collected upon, meaning 
that the team would be able to charge the entire plate instead of individual pins. Additionally, 
having multiple insulating covers would make transitioning between different fiber collection 
methods during the testing process fairly simple. This means that layers could be created within 
the same experiment, hopefully with mixed orientations.  
Limitations 
 
This would require developing additional shields for each desired fiber orientation, which 
our team determined to be the most inhibiting drawback. Also as fibers tend to collect on the 
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closest possible surface, which in this case could result in the collection along the cover, as the 
needles would not necessarily poke through the insulated layer (Figure 10).  
 
 
Figure 10: Isometric view showing the collection plate with a shielded cover 
 
Conductive Metal Backing  
The conductive metal backing can be seen in Figure 11. 
Benefits 
 
Creating this conductive backing would allow for the charging of only the desired rows, 
causing fibers to be pulled towards these specific pins. 
Limitations 
 
This would require developing additional conductive backings for each desired charging 
orientation.  
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Figure 11: Images of the conductive metal backing prototype with both a straight and curved orientation shown 
 
4.4. Feasibility Study/ Experiments 
A series of feasibility studies and experiments were performed to ensure the engineering 
design project was progressing in the correct direction. These studies included learning and 
optimizing electrospinning, determining feasibility of the pin matrix collection plate method, 
testing the effects of parafilm on cells, and scaffold seeding differences on different cell culture 
plates.  
Electrospinning is a very precise process that requires a lot of testing to optimize. A 
small-scale electrospinning setup, shown in Figure 12, was used to perform feasibility studies 
and experiments.  
In order to set operation parameters of the electrospinning setup, the team used the most 
simple collection plate form that is commonly used, an aluminum foil flat collection plate. This 
provided a cheap, easily changeable, sure collection plate that would not change while other 
parameters were altered. While using this collection plate, the flow rate, voltage, polymer weight 
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percent by volume, and distance were altered. These values were initially set based on the 
literature review, then optimized for this teams setup. A summary of some of these tests can be 
seen in Table 8. 
 
Figure 12: Electrospinning feasibility study setup showing the syringe pump, voltage supply, and collection plate. 
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PVA 
wt. % 
Distance 
needle to 
plate (mm) 
Diameter 
(mm) 
Extrusion 
rate (mL/hr) 
Collection 
plate 
Results/Observations 
15 30-80  1-.1 foil PVA stirred, no heat 
20 50  0.1 foil PVA stirred, heat. Fibers 
made for first time 
30 50  0.1 foil fibers but solution 
difficult to get in syringe 
25 50  0.1 foil created fibers, getting 
beads 
25 50  0.05 foil fibers 
20 36.8 0.08 0.05 pins fibers gathered on needle 
points 
20 36.8 0.08 0.02 pins fibers, collected on 
parafilm 
20 36.8 0.08 0.01 pins least beading, lots of 
fibers 
Table 8: Electrospinning feasibility experiment parameters and observations. 
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Figure 13: Initial collection of fibers on aluminum foil. 
 
In the end of the preliminary experiments, the team was able to create nanofibers on the 
collection plate as shown in Figure 13.  
With the electrospinning parameters refined, the next step taken was to test the feasibility 
of the pin matrix system for collection of nanofibers. This system is not readily used, so a 
feasibility study was necessary. To do this, similar electrospinning parameters were used as 
determined in the preliminary electrospinning feasibility study, but the collection plate used was 
changed from flat aluminum foil to the prototype 1 pin matrix collection plate. Figure 14 shows 
the polymer fibers collected to the pin matrix collection plate of prototype 1.  
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Figure 14: Initial fiber collection on prototype 1. 
 
Once the feasibility of the pin matrix system as a collection plate was determined, the 
ability of the collection plate to collect along a charged row was studied. When one row of pins 
was charged, the polymer fibers would collect and organize along those charged pins. Figure 15 
shows the collection plate with polymer fibers aligned across two rows. This multi-row scaffold 
was achieved by collecting along one charged row, then switching the charged row and 
continuing to electrospin. This alignment shows the feasibility of the pin matrix system to collect 
fibers along a defined charged row. 
  
Figure 15: Collection of nanofibers along charged rows.  
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4.5. Final Design Selections 
The final design for the electrospinning collection plate can be seen in the Figure 16 
below: 
Top View Bottom View 
 
 
Isentropic View Side View 
 
 
Figure 16: Images of our final prototype with leg extensions and brass cap fittings 
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This electrospinning collection plate pin matrix is made with a base insulating Delrin 
plastic with Stainless Steel minutien pins press fit into the plastic to make 10x15 pin matrix. 
These pins had a diameter of 0.4mm and a diameter at the pin tip of 0.03mm. This diameter 
allowed for a much finer matrix to be created to help foster more precise fiber orientations. The 
fine diameter at the tip of the pins was also advantageous as it concentrates the charge being 
applied from the voltage source at the very ends of the pins for precise fiber collection. The pins 
extended 25mm above the collection plate for fiber collection and 5mm on the back of the 
collection plate. The exposure of the pins on the backside of the collection plate allowed for 
customized charging of individual pins. The original pins were 38mm in length with a ball 
shaped head at the base of each pin. These pins were modified to a length of 33mm by removing 
the head of each pin. This was done to allow for the pins to be placed in the matrix 2mm apart 
without the heads on the pins colliding with one another. Removal of the head on the pins also 
allowed for a more effective method of charging individual pins. The dimensions of the 
collection plate in inches can be seen below (Figure 17): 
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Figure 17: SolidWorks Drawing of the final prototype 
 
The method of charging the pins on the backside of the collection plate was achieved 
through a brass cap method. Brass caps were drilled with holes on each end (Figure 18): 
 
Figure 18: Shows the hole cut into each brass cap fitting 
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Each hole was equivalent to the diameter of the pins in the collection plate. One end of 
the cap was used for the charging of individual pins by being press fit onto any pin of choice. 
The other hole allowed for an electrical wire to be inserted and soldered into the hole to help 
achieve an electrical current to the caps (Figure 19): 
 
Figure 19: Brass cap fitting attached to soldered wire 
 
These caps allowed for any pin to be charged, which allowed for unique shapes and 
patterns of fiber collection to be achieved. The wires extending from each brass cap were weaved 
together at the ends. The weaving of the wires allowed for the alligator clip of the 
electrospinning unit to charge all of the brass caps at once (Figure 20): 
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Figure 20: Wires weaved together, secured with electrical tape and charge via alligator clip 
 
For this research project, the brass caps were placed on the pins in a curved orientation to 
charge pins in this orientation and produce a curved PCL fiber scaffold.  
Because the brass caps were longer than the legs of the collection plate, the collection 
plate was modified. The height of the collection plate needed to be increased to allow for 
clearance of the brass pins when the collection plate was taped to the rubber backing. 10 mm of 
Delrin plastic was added on two opposing sides of the collection plate to increase the height. 
Therefore, extending the length of the sides of the device allowed for the brass caps to be placed 
on the pins and the collection plate to be tapped to the rubber backing at the same time.  
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Collection Plate Material Selection 
Material Function Advantages Disadvantages Chosen 
PVC Collection plate 
base 
~Insulating 
plastic 
~Not easily 
manufactured  
~Shrinking and 
swelling of holes 
during 
manufacturing 
No 
Delrin Collection plate 
base 
~Insulating 
plastic  
~Easily 
manufactured  
N/A Yes 
Stainless Steel 
Minutien Pins 
Collection plate 
pins 
~Decent 
electrical 
conductivity  
~Small diameter 
~Fine pin tip 
~Not optimal 
electrical 
conductivity  
Yes 
Brass Cap Pin charging  ~Strong 
electrical 
conductivity  
~Easily 
manufactured 
N/A Yes 
Table 9: Collection plate material selection analysis 
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The materials that were chosen to manufacture the collection plate were Delrin plastic for 
the base, the stainless steel minutien pins, and the brass caps. Although the stainless steel 
minutien pins did not provide the optimal ability to conduct electricity compared to other metals, 
the small diameter provided for stronger advantages. The diameter of the pins allowed for a fine 
matrix to be created, thus, improving the precision of fiber alignments. The fine diameter at the 
tip of the pins helped concentrate the voltage at a very specific point on the pins, which helped 
for organized fiber collection. The Delrin plastic was chosen over the PVC plastic because the 
Delrin plastic was easily manufactured in comparison to the PVC. When drilling the holes into 
the plastic to create the pin matrix, the PVC plastic heats due to friction with the drill and the 
holes expand to larger holes than desired and later shrink when the plastic cools. This behavior 
of the PVC does not allow for accurate manufacturing.   
Design Benefits vs. Drawbacks 
Benefits Drawbacks 
Customized pin charging/fiber alignment Difficult for user to manually apply brass caps 
for pin charging 
Fine pin matrix for precise control of fiber 
alignment 
Difficult fiber removal process 
Reproducible scaffold creation   
Compatible   
Portable   
Table 10: Benefits and drawbacks table for our final prototype 
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This collection plate design met the main requirements that were desired for the goal of 
electrospinning customizable polymer fibers. This collection plate and brass cap method allows 
for any pin orientation to be charged, thus, allowing for any fiber alignment to be achieved. This 
collection plate also allowed for a reproducible procedure when creating polymer scaffolds. It 
also is a compatible design that can be used with any electrospinning unit and is easily 
transportable. Areas of improvement include the ability of the fibers to be removed from the 
collection plate in a more effective manner. Lastly, because the brass caps were a press fit to the 
pins and the pins were also a press fit into the collection plate base, it was difficult to manually 
apply the brass caps to the pins for charging as some pins would become dislodged at times. 
Overall, the advantages this collection plate provided outweighed the drawbacks.  
Preliminary Experimentation 
Based on preliminary experimental results, modifications to the project were made. The 
original electrospinning unit that was being constructed did not allow for voltages above 10kV to 
be reached (Figure 21): 
 
Figure 21: Initial electrospinning setup from A Term 
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From research, this voltage was not high enough for effective electrospinning testing. The 
team researched the availability of a sufficient voltage source but could not find one within a 
range that could be supported by the budget. Therefore, the team was granted access to use the 
electrospinning unit in Professor Anjana Jain’s Lab. The voltage source in the Jain Lab had the 
capability to reach voltages of 30kV (Figure 22): 
 
Figure 22: Electrospinning setup from Jain Lab utilized for all testing B-D Term 
 
Initial electrospinning testing was being completed with polyvinyl alcohol (PVA) 
solution. The PVA solution was dissolved in distilled H2O and experimented at 10, 15, 20, and 
30 weight percent. PVA was primarily used as an electrospinning material to help with the proof 
of principle that straight and curved aligned fibers could be achieved. Advantages of using this 
material for initial testing was that it was readily available, did not cost money, and was simple 
to dissolve into solution. These advantages made PVA a great initial polymer to test the proof of 
electrospinning varying fiber orientations with. However, the group moved from PVA to PCL 
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once it became time to start seeding the polymer scaffolds with cells. This is because PVA is a 
rapidly degrading polymer when in contact with cell media. Therefore, PCL became the primary 
polymer used when electrospinning scaffolds to seed cells with. The two major advantages it 
provided over PVA was its structural integrity and its ability to promote cell adhesion to the 
scaffold.  
The early stages of electrospinning were also completed with Prototype 1. This prototype 
was a proof of principle model as well. The goal with this electrospinning collection plate was to 
prove that polymer fibers could be collected in a straight aligned fashion. Once straight fiber 
alignment had been achieved, the final collection plate pin matrix was designed to allow for 
customizable fiber orientations. The initial prototype proved the concept that fiber alignment 
could be controlled with the pin matrix method. This allowed the group to move forward with a 
more advanced collection plate as a final design that promoted customizable fiber alignment 
using the pin matrix method in a more refined manner.  
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5. DESIGN VERIFICATION 
This project used electrospinning technology to create customizable polymer fiber 
alignment. A curved fiber orientation was desirable to mimic the fibers that exist within the 
meniscus. The curved fibers were then taken and seeded with ATDC5 cells and a GFP 
expressing cell line to prove that cells could attach to the scaffold.   
5.1. Electrospinning 
For the final collection plate design, the main goal was to use electrospinning technology 
to create custom aligned fiber scaffolds to be used for cell seeding to prove that native tissues 
orientations within the body can be mimicked. Through preliminary testing with Prototype 1, the 
group was able to prove that straight aligned fibers could be achieved with a pin matrix method. 
A final collection plate was designed and tested with a 10% PCL polymer solution dissolved in 
HFIP. This formulation was proven to be successful in previous research as the team would 
make batches of PCL solution that could be used for up to three weeks before needing a fresh 
PCL solution. The PCL formulation for electrospinning can be seen in the table below: 
PCL Mass HFIP Volume Dissolving time on magnetic 
stir plate 
0.5g 5.0ml 24 hours 
Table 11: 10 % weight PCL Electrospinning Solution 
 
With the final collection plate design, the initial tests were conducted to produce straight 
aligned fibers to validate that the pin matrix design and pin charging method could support 
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controlled fiber alignment. An image of the straight fiber alignment can be seen below (Figure 
23): 
  
Figure 23: Straight fiber collection on parafilm using final prototype 
 
Once straight aligned fibers were achieved, curved PCL fibers were then created. After 
extensive experimentation, the optimal parameters for creating curved PCL fiber scaffolds are 
featured in Table 12 below:  
Test 
duration 
Voltage 
range 
Flowrate Syringe 
diameter 
Distance 
from syringe 
tip to pin 
matrix tips 
10% PCL 
solution 
volume 
15-20 
minutes 
8-12kV 0.15ml/hr 12.06mm 10cm 0.5-1.0ml 
Table 12: Electrospinning Test Parameters 
 
Curved fibers were created to mimic the native fiber alignment of meniscal 
circumferential fibers. The electrospinning procedure was able to produce these curved scaffolds 
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consistently. This test procedure is repeatable as the results were mimicked on numerous 
occasions. Images of the scaffolds can be seen below (Figure 24): 
  
Figure 24: Successful curved alignment along charged brass caps with final prototype 
 
The electrospinning process for creating curved fibers worked very effectively at times 
but due to certain factors, the quality of electrospinning could be inhibited. Weather conditions 
had an impact on the success of electrospinning curved scaffolds. When the weather was 
abnormally dry, internal static was created and often caused fiber collection to be much more 
scattered and random or for the fibers to collect in a non-optimal location. On the contrary, if the 
weather was abnormally humid, the fibers tended to be clumpier and cause dripping at the 
syringe tip. Weather conditions caused fluctuations in the results depending on the humidity 
levels in the air. Improper cleaning of the syringe tip also inhibited the electrospinning of PCL 
scaffolds. The PCL solution could solidify in the syringe tip if the tip was not cleaned between 
each test, causing difficulty for the solution to be extruded. The images below indicate a proper 
Taylor cone, a clumpy solution, and random fiber collection due to internal static (Figure 25): 
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Figure 25: Shows the Taylor cone formed from the syringe needle and fiber collection 
 
5.2. Cell Seeding 
Cell seeding of the scaffold could only begin once electrospinning produced results with 
the collection plate.  The team conducted a population doubling study with a cell line of mouse 
chondrocytes, ATDC5. The cell culture procedure followed can be found in Appendix A. The 
numerical results of the study can be seen in Table 13 and visually in Figure 26: 
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Days Starting Cell # 
Ending Cell 
# PDL Cumulative PDL 
0 1.00E+05       
6 1.00E+05 3.85E+06 5.26E+00 5.26 
12 1.00E+05 4.60E+06 5.52E+00 10.78 
18 1.00E+05 2.45E+06 4.61E+00 15.40 
Table 13: Population doubling study results 
 
 
Figure 26: Population doubling study results 
 
The population doubling study allowed the team to plan out sub culturing and timing for 
future experiments. The team also practiced cell freezing and thawing. These procedures can be 
found in Appendix A.  
The team met with members of the Gaudette lab as well as with Alex Beliveau. Alex 
worked with seeding electrospun PCL and the team created a scaffold seeding protocol based on 
his experiences. 
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Once scaffolds of PCL were being created with prototype 1, cell seeding began. ATDC5 
were seeded with the protocols found in Chapter 6. The cells were difficult to visualize on the 
scaffold. To increase visibility, a GFP expressing variant of breast cancer cell line MDA-MB-
231 were used.  The scaffolds were seeded at a density of 250,000 cells per mL and 750,000 
cells per scaffold. After seeding, the cells were imaged for three weeks. Below are the GFP 
expressing cells seeded onto PCL scaffolds (Figure 27). 
Days     
1 
 
Brightfield, 5X 
 
FITC, 5X 
 
 
2 
 
Brightfield, 10X 
 
 
Brightfield, 20X 
 
FITC, 10X, 18ms exposure 
 
 
FITC, 20X, 18ms exposure 
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6 
 
Brightfield, 10X 
 
FITC, 10X 
 
 
7 
 
Brightfield, 10X 
 
FITC, 10X, 60ms exposure 
 
Hoechst, 10X, 60ms 
exposure 
8 
 
FITC/Hoechst, 20X 
 
FITC, 20X 
 
Hoechst, 20X 
Figure 27: Images taken daily of PCL scaffolds seeded with GFP expressing cells 
 
To determine PCL degradation time, one scaffold remained seeded in media for a month. 
The degradation of the PCL could be seen with the naked eye after two and a half weeks. At this 
time point, the cells were no longer clearly visible, and appeared to be dying.   
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6. FINAL DESIGN AND VERIFICATION 
Based on the battery of tests that the team performed using the electrospinning setup we 
determined that our device was successful as we proved the ability to control the fiber alignment 
along multiple orientations with the brass cap grounding method as well as meeting each of our 
objectives as described below. 
6.1. Objective Verification 
Verification of each of our previously described objectives are outlined in this 
subchapter. 
Safe 
This objective focused on the ensuring that the designed collection plate would not 
remain active if the operator touches said plate after the completion of an electrospinning cycle. 
The safety of the electrospinning operation was established with a two-tiered approach: (1) 
establishing that the voltage supply was shut off before attempting to touch the collection plate 
and (2) the plastic enclosure, which prevented the user from accidently touching any charged 
portion of the electrospinning setup during the fiber collection process.  
User Friendly 
Regarding this objective, the team achieved the desired function for the proof-of-concept 
and has subsequently set in place more refined guidelines to be used in future prototypes given 
more time and department funding to produce. Specifically, this entails a simplification of the 
conduction step that currently consists of installing each individual pin with a conductive brass 
cap to ensure connection with the other pins for a desired orientation. Refinement of this process 
will allow for easier transition between various fiber alignment shapes to better model the 
conditions present in cartilage/tissue scaffolds. In relation to portability, our proof-of-concept 
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represents a fairly mobile device with the small restriction that the brass caps may be subject to 
shifting depending on the nature in which they are handled as each is installed in a double press-
fit fashion. While there are a fair amount of parts due to the fine pin matrix, these will be 
attached during the manufacturing process meaning that the only additional part to be attached is 
the cluster of conductive brass caps.  
Manufacturability  
During the development and manufacturing process, the team modified segments of the 
final collection plate design to best fit the standard drill bit sizes available within the Goddard 
Hall machine shop. Given this restriction, we narrowed our search down to pins of 0.4 mm 
diameter, equivalent to an available drill bit size of 0.016 inches. While this modification slightly 
limited our possible pin sizes, the varying accessible drill bit sizes offer a wide range of available 
pin diameters that hardly limited our desired sizing requirements. This prototype was produced 
with the help of Tom Partington, the Goddard Hall machine shop Lab Manager, who developed 
them by hand, cut from a block of polyoxymethylene (Delrin). In the future if predetermined 
design specifications are established for mass production, the development process could be 
streamlined and automated to enhance the efficiency and precision of each plate design.  
Customizable 
Within the scope of our project, the customizability of our design was focused on the 
ability to adjust to different charged pin orientations. In this respect, our final prototype has 
succeeded in producing all possible orientations when including between 1-21 pins as the team 
prepared, wired and soldered a total of 21 brass cap fittings for the purpose of our testing. This 
customizability comes with the stipulation that there is a small margin between connected pins as 
83 
 
the fibers tend to seek out the closest possible collection areas in regards to the charged 
collection plate sections, thus inhibiting large jumps from one charged pin to another. 
Electrospinning Compatible 
Referencing the electrospinning syringe pump setup, our testing has proven that our 
collection plate method is viable with this electrospinning approach, whereas the gravity-induced 
pump has yet to be determined but based on our research, the gravity-induced pump collection 
can be controlled based on the collection plate angle, which is comparable to modifications in the 
flow rate of the polymer solution in syringe pump induced electrospinning (Thoppey 2010). 
Additionally, our team protected against unnecessary confounding variables by confirming that 
the materials used to create the collection plate, not including the conductive pins, were 
insulating and would not misdirect the conduction to non-metallic portions of the collection 
plate. 
6.2. Final Prototype Experimental Methods 
Once the team prepared their final collection plate for electrospinning tests, the initial 
tests were performed using polyvinyl alcohol (PVA) to eliminate possible confounding variables. 
Once these tests were deemed successful, the team shifted their focus to polycaprolactone (PCL) 
due to its higher biocompatibility to promote cell adhesion and survival.  
Once this polymer change was made, the first three rounds of testing were run under the 
following conditions: 
Solution of 10 % PCL (w/v), Syringe to plate distance of 15 cm, with a fluctuating voltage 
between 10-15 kV and tests were run for between 10 – 20 minutes depending on fiber control. 
After meeting with Alex Beliveau who had previous experience spinning with PCL, he 
recommended moving the plate closer to the syringe tip to inhibit random collection and testing 
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at lower voltages to allow for more controlled fiber collection. After this meeting the testing 
conditions were adjusted to our final specifications of: 
Solution of 10% wt. PCL (w/v), Syringe to plate distance of 10 cm, with a lower voltage range of 
8-10 kV and tests were run between 10 – 15 minutes.  
6.3. Electrospinning Protocol 
The following procedure describes the process to electrospin customized 
Polycaprolactone (PCL) fibers, specifically in a curved orientation.  
PCL Solution Preparation  
(10% weight PCL in 1,1,1,3,3,3 – Hexafluoro – 2 – propanol (HFIP) (Figure 28)) 
 
Figure 28: PCL and HFIP Solution used for polymer dissolution 
 
1. Obtain 0.5g of PCL by weighing the PCL in a weigh boat on a scale. The scale should be 
zeroed with the weigh boat on the scale before the PCL mass is measured. 
2. Place the 0.5g of PCL and a magnetic stir bar into a plastic capped vial (Figure 29): 
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Figure 29: Vial containing stir bar and PCL  
 
3. Bring the HFIP bottle, a stir plate, tape, pipetter, 5ml pipette tip, and the vial with 0.5g of 
PCL to a sterile lab hood. 
4. In the hood, remove the cap from the HFIP bottle and extrude 5ml of the solvent. Place this 
5ml of HFIP into the vial with 0.5g PCL and the magnetic stir bar. 
5. The plastic capped vial should now have a 10% PCL weight solution in HFIP. 
6. Cap the vial loosely (in order to ensure pressure buildup does not occur) and place the vial 
onto the magnetic stir plate. Tape the vial onto the stir plate to secure it to the plate as seen in 
the image below (Figure 30): 
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Figure 30: PCL dissolution process on a stir plate, secured with tape 
 
7. Turn on the magnetic stir plate to allow for the solution to be mixed. If the stir bar is not 
stirring properly, remove the cap from the vial and stir the solution manually with a sterile 
rod to dislodge the stir bar. Once the stir bar is unstuck, place the vial back onto the stir plate 
with the cap on lightly and tapped to the stir plate. 
8. Label the vial with the project name, date, and weight percent solution that has been made.  
9. Allow for the solution to mix for 24 hours before using to electrospin.  
10. Each PCL solution that is created has a shelf life of 2-3 weeks.  
11. When the PCL solution has been mixing for 24 hours, remove the vial from the stir plate and 
cap the solution tightly. Use parafilm to cover the cap and seal the vial from allowing the 
solvent in the solution to evaporate (Figure 31).  
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Figure 31: Mixed PCL solution covered with parafilm to prevent evaporation 
 
12. Store the solution at room temperature. 
Controlled Fiber Alignment Electrospinning Procedure 
1. Obtain a 5ml syringe, 22-gauge stainless steel syringe tip, and 10% PCL solution. 
2. In a sterile lab hood, extract 0.5 to 1.0ml of solution into the syringe through the stainless steel 
syringe tip (if the solution cannot be extracted through the syringe tip any longer, it has 
become too thick and is no longer suitable for electrospinning). Cap the PCL solution tightly 
and seal the cap with parafilm to minimize evaporation of the HFIP. Store the vial at room 
temperature.  
3. Remove all air bubbles from the syringe and syringe tip. 
4. Obtain a syringe pump and place it into the electrospinning unit. Turn on the syringe pump 
and set the syringe diameter to 12.06mm and the flowrate to 0.15ml/hr. The flow rate can be 
adjusted to a faster flowrate if the polymer is not being drawn from the syringe tip or 
adjusted to a slower flowrate if the polymer is dripping from the syringe tip. 
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5. Place the syringe with the PCL solution on the syringe pump and secure it into place with the 
syringe placed as forward as possible, the top clamp tightened over the syringe, and the 
moving plate in contact with the back of the syringe (Figure 32): 
 
Figure 32: Syringe with PCL secured in the injection pump holder 
 
6. Obtain the pin matrix collection plate and on the back of the collection plate, place the brass 
caps onto the pins that desired for charging. For a curved fiber collection, the brass cap 
orientation should be similar to Figure 33 below: 
 
Figure 33: Final collection plate set up with curved charging 
89 
 
7. Using electrical tape, cover the other brass caps that are not being used to charge the collection 
plate. 
8. Obtain a pair of scissors and cut a 2x2 inch piece of parafilm. Place the parafilm onto the 
collection plate pin matrix so that the tips of the pins are exposed. A flat-head stainless steel 
rod can be used to assist in applying the parafilm over the collection plate to expose the 
heads of the pins through the parafilm (Figure 34): 
 
Figure 34: SS rod used to lay parafilm onto pin tips 
 
9. Using electrical tape, cover the collection plate onto the rubber backing so that the pin matrix 
is at the same height as the syringe tip. 
10. Place the collection plate 10cm from the syringe tip measuring the distance from the end of 
the syringe tip to the tips of the pins on the collection plate.  
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11. Attach the positive lead from the voltage source (the green alligator clip) to the syringe tip 
and attach the negative lead (the yellow alligator clip) to wire endings of the brass caps 
(Figure 35): 
 
Figure 35: Shows the alligator clips grounding the plate and charging the syringe needle 
 
12. Start the syringe pump.  
13. Close the door to the electrospinning unit. Do not ever have the door open or any body parts 
close to the electrospinning unit while the voltage source is on.  
14. Turn on the voltage source and adjust the voltage to 10kV (Figure 36). The voltage can be 
adjusted between 8-12kV during the test if needed. If the polymer is dripping from the 
syringe tip, increase the voltage that is being applied. If the polymer is not visible from the 
syringe tip, decrease the voltage until a proper Taylor Cone is achieved.  
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Figure 36: Voltage supply utilized for testing in Jain’s Lab 
 
15. Run the test for 15-20 minutes or until the desired scaffold thickness has been created. The 
test/voltage may need to be stopped during the duration of the test to remove excess fibers 
that are inhibiting proper fiber collection. Use chem-wipes to remove any of these excess 
fibers. 
16. When the test is complete, turn off the voltage source. Remove the alligator clips from the 
syringe tip and the collection plate. If another test is going to be run, clean the syringe tip out 
with acetone.  
17. Carefully remove the parafilm from the collection plate pin matrix so that the fiber 
orientation is preserved. Remove the parafilm manually with two hands. 
18. Label the parafilm with the test number, the date, and the polymer solution that the fibers 
were created from.  
19. Place the scaffold on the parafilm in a container and store it at room temperature for 24 
hours.  
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20. Put all materials back where they were stored. Clean any excess fibers off of the collection 
plate pin matrix and using 70% isopropanol clean the rubber backing used to hold the 
collection plate.  
6.4. Scaffold Seeding Procedures 
This subchapter highlights the scaffold removal and scaffold seeding procedures used. 
Scaffold Removal Procedure 
1. Obtain forceps and non-tissue culture dish. 
2. Remove scaffold and parafilm from container after a minimum of 24 hours. 
3. On lab bench, carefully remove scaffold from parafilm with forceps starting at aligned 
row and lifting towards edge of the parafilm. 
4. Place scaffold into open petri dish. 
5. Place lid on petri dish. Avoid dragging or rubbing dish as to not create static electricity. 
6. Label petri dish. 
Scaffold Seeding Procedure 
1. Place petri dish with scaffold into UV sterilizer. Leave lid on petri dish. 
2. Turn on sterilizer by flipping bottom button to on position. 
3. Expose scaffold and dish to UV light for 30 minutes. 
4. During sterilization time, follow cell culture procedure steps 2-15 with cells in incubator. 
5. Re-suspend cells in sufficient amount of media to create a cell suspension with a density 
of 250,000 cells/mL. 
6. Remove petri dish from sterilizer and bring to culture hood. 
7. Clean dish with 70% isopropanol and place in hood. 
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8. Fill 10mL pipette with cell suspension. 
9. Lift petri dish lid up just enough to pipette cell suspension on to the scaffold. Do not 
remove lid entirely or blowing air will interfere with scaffold alignment. 
10. Pipette until scaffold is entirely covered with suspension. Do not cover entire bottom of 
dish and pipette only where scaffold is present.  
11. Count number of drops to be able to calculate total cell count. 
12. Place lid on petri dish. 
13. Gently move dish to incubator. Avoid moving scaffold in dish or displacing cell 
suspension from scaffold.  
14. After six hours, pipette media into sides of dish. Entire bottom of dish should now be 
covered. 
6.5. Validation process methods 
The regulations are very stringent for devices used for medical purposes. However, the 
designed collection plate will currently only be used for research purposes, so the regulations are 
not as strict. However, there are still engineering standards that would need to be followed for 
manufacturing and marketing the designed collection plate.  
One resource used to find standards to follow is www.nssn.org/search/IntelSearch.aspx 
which is a search engine provided by American National Standards Institute (ANSI). Below is a 
list of some standards that would need to be considered to manufacture and market the developed 
collection plate design. One standard to highlight would be the ISO 9000 series, which define, 
establish, and maintain a quality assurance system for manufacturing. Another highlight would 
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be the family of standards ISO 14000, which works to help organizations decrease their negative 
effect on the environment and increase compliance with laws and regulations. 
x ISO 9000 – Quality standard 
x ISO 14000 – International Environmental Management Guideline (standard) - product 
life cycle and sustainability standard for business, industry, and engineering design 
x ANSI/ASME Y14.1 and Y14.5 – International drafting standards for engineering 
drawings 
x ANSI B11.20-2004 (R2015) -- Safety Requirements for Integrated Manufacturing 
Systems 
x B11.TR7-2007 – Designing for Safety and Lean Manufacturing: A guide on integrating 
safety and lean manufacturing principles in the use of machinery 
x ISO 1101 – Geometric Dimension and Tolerancing Standard 
x ISO/IEC Guide 60:2034 – Conformity assessment – Code of good practice 
x IEC 60060 Ed. 3.0 b:2010 – High-voltage test techniques 
6.6. Effects and Considerations 
The results of this project can have many effects, and there are many factors for the team 
to consider. The following list was compiled to show the thoughts behind some considerations of 
the potential effects of this project, including economics, environment, societal, political, ethical, 
health/safety, manufacturability, and sustainability.  
1. Economics: This project has the ability to greatly affect the economics of the nation. One 
opportunity for this device to affect economics is if it progresses to the point where a 
tissue-engineered meniscus can be implanted into patients. This would have a great 
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impact on economics, as meniscus injury is a four billion dollar market. In the short term, 
this device has the ability to affect the economics on a smaller scale. Research labs 
around the world are using scaffolds for a wide variety of purposes. The desire to make 
tissue engineering more biomimetic persists, and this projects device provides just that. If 
research labs want to use or make customized scaffolds, this device can be used to make 
the custom scaffolds then sold to the lab or the lab could buy the collection plate directly 
and use it in the lab to create their own custom scaffolds.  
2. Environmental impact: The project impacts the environment by using synthetic polymers 
and organic solvents. The new collection plate design required less solvent and solute due 
to the higher level of control over the polymer extrusion. The level of waste reduced and 
so did the polymer and organic solvent needed initially. Use of organic solvents impacts 
the environment as well. Organic solvents release volatile compounds into the 
atmosphere. On a large industrial scale, the compounds can create smog. The organic 
solvent HFIP had a half-life of one to seven days in the atmosphere and one to five days 
in water.  
3. Societal influence: This technology and this product specifically have the ability to 
influence many lives in a positive way. Meniscus injuries are very common in athletes 
and ordinary people. These injuries often can be detrimental to the quality of life of the 
individual who has sustained the injury. There is currently a gap in treating significant 
meniscal tears to help patients reach full health again due to the avascular nature of the 
meniscus. Customizable fiber orientations in a curved alignment that mimics the fiber 
alignment within a meniscus could be used to support the growth of patient specific cells. 
This technology could significantly advance how meniscal tears are treated. Mimicking 
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the fiber alignment of a meniscus and seeding the artificial scaffold with patient specific 
cells could potentially allow for the most advanced meniscal replacements to this day. 
The functionality of the replacement meniscus could most effectively be achieved 
through mimicking the orientation native tissue itself. Not only does this product have the 
ability to change the way meniscus injuries are treated, but also how other tissues in the 
body can be mimicked. This technology could be used to develop fiber orientations that 
mimic any native tissue in the body. This versatility can then be used to create treatment 
options for any injury to any type of tissue by most accurately mimicking the structure 
and form of any tissue of interest.  
4. Political ramifications: Based on the team’s foreseeable scope of this project, the 
potential political impacts are very minimal as the intended use of our design is to allow 
for research and teaching opportunities for university laboratories. The only concern our 
team could determine from this design is if the produced fibers were then used for 
controversial purposes, which could lead to political friction on the utilization of the 
technology. For example, these could include the use of stem cells for seeding onto the 
align fibers but given the team’s level of operation, this was not deemed to be a serious 
concern.  
5. Ethical concerns: This project is extremely ethical as it aims to solve a gap in the medical 
field to help treat patients who need replacement tissues after sustaining an injury or 
losing function. Specifically, this project focused on the challenge with treating meniscal 
tears. Therefore, the target population is individuals who have meniscal injuries. 
However, this technology has the potential to mimic many different types of tissues in the 
body, thus, allowing this technology to cover a wide range of patient needs. The 
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fundamental goal that this product is trying to achieve is to improve the quality of living 
of a patient in need. Whether that need be an engineered meniscus implant or a cardiac 
muscle implant, this technology can potentially be used to help these types of individuals 
improve their quality of living.  
6. Health and safety issue: The collection plate as designed is a research tool for three 
dimensional tissue scaffolds. The ideal future use would involve implanting ex vivo 
tissue within the body for tissue replacement or repair. One example would be with 
replacement meniscus. It would increase the standard of care for the health industry. 
7. Manufacturability: Manufacturability in this case can be broken down into two 
categories, the collection plate pin matrix and the customized scaffolds. The collection 
plate pin matrix can be easily manufactured in large quantities, with minimal materials, 
and efficiently. The procedure for producing the collection plates could be improved to 
an automated production line as the plastic base could be developed through simple 
machining and the pins secured into the plastic base. With an automated manufacturing 
procedure, the collection plates could be created in mass quantities without sacrificing 
time or cost. On the other hand, manufacturing the customized scaffolds is also 
achievable. Electrospinning experimentation would not allow for the scaffold creation to 
be as time efficient as the collection plate manufacturing. However, with multiple 
electrospinning units, the ability to efficiently manufacture scaffolds significantly 
improves. Scaffold creation requires very minimal material and would be relatively cheap 
to produce.  
8. Sustainability: The base of the collection plate is made out of insulating plastic. If mass-
produced, the base can be made out of a recycled thermoplastic and reformed to be used 
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as the base material. This would decrease the need for synthesizing more plastic for 
production.  
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7. DISCUSSION 
Electrospinning is very attractive due to the extremely high surface area to volume ratio it 
produces. A high surface area to volume ratio means that more cells can be seeded more densely 
on the scaffold. Electrospinning also allows for high control of the fibers diameter. However, 
current electrospinning methods provide limited control of fiber arrangement.  
The team improved the most advanced pin matrix collection plate. The team’s collection 
plate had a finer pin matrix as well as conductive backings to allow for different fiber collection 
shapes. The finer a pin matrix is, the more flexibility there is when attempting to mimic tissues 
within the body. Moving from Prototype 1 to the final collection plate design indicates that a 
finer matrix allows for micro-geometries in the body to be mimicked with improved accuracy. 
The collection plate was compatible with varying test parameters including, changing voltage, 
materials, and polymer flow rate.  
One of the main benefits of the plate was the design’s ability to be integrated into 
different electrospinning machines. The plate design can replace current system’s flat collection 
plates. Most strategies for alignment seen in literature require applying an additional external 
force to the fibers. For example, containing fibers in chambers of flowing gas can induce straight 
fiber collection. This adds another piece of expensive equipment into the process as well as 
needing to stock gaseous material. 
The largest advancement the collection plate added to the electrospinning process was 
fiber alignment customization. The user may choose the orientation the fibers align in by 
changing the orientation of the brass caps on the back of the plate. As a proof of concept, curved 
scaffold alignment was created but this was one of the many possible shapes the team could have 
created. This a function that is not available on the electrospinning market, especially within one 
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device. Customized fiber alignment is an area of electrospinning that can be used to mimic 
various tissues within the body. This technological advancement provides tremendous potentially 
to treating tissue-engineering needs, such as replacement menisci for patients with significant 
injury to this cartilage tissue.  
The collection plate design also was able to produce scaffolds consistently. Various tests 
were conducted with the collection plate and the design and procedure were able to consistently 
produce scaffolds of curved fibers. There were times where complications arose and certain 
scaffolds were not as high of quality compared to other scaffolds. However, the results were 
reproducible for creating scaffolds.  
The safety level and user friendly level of the collection plate design was achieved but 
could be improved. The collection plate pin matrix is hazardous for the user and can easily 
puncture the skin of someone using it for testing. If the collection plate is handled properly and 
transported properly then the safety is not as much of an issue. It is very small and compact, 
which makes it easy to handle and easy to bring between different labs. The proper transportation 
method to improve safety for the user is to transport the device in a container. Along with that, 
when handling the collection plate, the user must just be aware and cautious that the pins are 
exposed. It is a lightweight device and easy to handle in the lab but should be used with caution. 
As mentioned before, it is user friendly in the sense that this device can be used for any 
electrospinning setup and is easily used during electrospinning. The one major downfall for the 
user is that the pin-charging method with the brass caps is manual and tedious procedure.  
7.1. Cell Seeding and Alignment 
Through the project experiments many results were obtained regarding cell seeding and 
alignment. The team was able to show that cells could grow on and throughout the PCL scaffold. 
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Additionally, the cells aligned along the created fiber alignment. This means that the designed 
collection plate can control fiber alignment, therefore controlling final cell alignment. This is a 
very useful ability to have. A major limitation to tissue engineering and regenerative medicine is 
the lack of functionality the engineered tissues have. Better mimicking the microenvironment 
and macro-environment of native tissues may help the engineered tissues function closer to 
native tissues. For example, the circumferentially aligned fibers and cells allow for a high 
compressive strength with all the GAG's present in the tissue. The compression pushes down on 
the tissue, which then pushes out on the circumferential fibers. If engineered scaffolds mimic this 
circumferential fiber alignment, the resulting tissue may be able to support similar compressive 
forces. 
The PCL nanofiber scaffold remained in geometry for 2-3 weeks in cell media. This is 
enough time to observe cell attachment and alignment on the scaffold fibers. However, the 
desirable degradation time should be explored more moving on in this project. The idea of this 
scaffold is to allow for cells to be seeded to the scaffold, align in the custom fiber orientation, lay 
down their own extracellular matrix mimicking the custom fabricated matrix, then have the 
polymer degrade away. The exact time frame for when the ECM would be produced needs to be 
balanced with the polymer degradation time. 
7.2. Assumptions 
One assumption is that mimicking native tissues through custom alignment is better and 
will lead to an increase in functionality of the final engineered tissue. The need for improving 
tissue engineering is to improve the functionality of the engineered tissue. The idea that 
mimicking native tissues more closely will lead to better functionality is one that is believed 
throughout the tissue engineering and regenerative medicine field.  
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Another assumption that was integral to the proof of concept of this project is that 
because cells attached to the straight aligned fibers they would also attach to curved fibers. Cell 
seeding of scaffolds primarily focused on promoting growth along the straight aligned fibers. 
Minimal cell seeding was done on the curved scaffolds. The fiber handling process was also not 
effective enough, therefore, removing fibers from the collection plate and to the culture dish 
often resulted in compromising of the fiber orientation. Because it was difficult to maintain the 
curved nature of the scaffolds, it became difficult to test whether or not the cells would attach 
and grow along the curved fibers that were created. Cells were proved to be able to grow along 
straight aligned fibers, from which the group made the assumption that the cells would also grow 
along curved fibers.  
A GFP expressing cell line was used to seed the scaffolds with in order to improve 
imaging capabilities of the cell behavior on the fibers. The GFP cell line that was used was not a 
chondrogenic cell line that is seen in the meniscus. Therefore, the group made the assumption 
that the chondrocytes or patient specific cells would behave like the GFP expressing cell line in 
the sense that the cells would attach and grow on the fiber scaffolds.  ATDC5 cells were opted 
against when seeding the scaffolds because the ability to collect useful images of these cells on 
the scaffold was extremely challenging. As a proof of principle, the GFP expressing cell line was 
chosen to improve imaging capabilities, thus, rendering the assumption that patient specific cells 
would provide similar results when being seeded to a scaffold.  
The current gold standard for electrospun scaffolds is the Mimetix scaffold. Table 14 
compares Mimetix to this project's final design.  
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Attribute Mimetix Final Design 
Electrospinning machine 
Setup 
Syringe pump Syringe pump 
Collection plate Rotating drum Pin matrix 
Scaffold material PLLA PCL 
Fiber alignment Random/Straight Customized by user 
Scaffold coating Customized by company N/A 
Scaffold removal N/A Needed 
Cell seeding Successful in 3D Successful in 3D 
Custom Alignment No Yes 
Table 14: Comparison between the Mimetix and custom scaffold 
 
There are similarities and differences between the attributes. Both electrospinning 
machines used voltage and a syringe pump with a single extrusion needle to pull polymer 
solutions into fibers.  
The two collection plates varied, resulting in major differences in fiber alignment. The 
rotating drum pulls randomly aligned fibers along its circumference to form straight alignment. 
The team's collection plate grounds pins to align fibers along the pin tips. This collection plate 
allowed the team to create customized alignments while the Mimetix scaffold is available in 
straight or random alignments. 
There were different material choices for the two scaffolds. The Mimetix used PLLA that 
degrades very slowly in culture while the team chose PCL for degradation time of four weeks. 
Both materials have the potential to be coated prior to cell culture, such as with collagen. 
Mimetix offered this as a customizable option but is not necessary for cell culture. For scaffold 
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seeding, the Mimetix scaffold requires preconditioning 12 hours before use and the custom 
scaffold needs twenty-four hours after electrospinning to allow the organic solvent to fully 
evaporate. Overall, both scaffolds are successful in 3D cell culture.  
One drawback of the team's scaffold design is increased handling by the user. The 
scaffold needs to be removed from the collection plate and placed in a petri dish for seeding. The 
Mimetix scaffold comes in a petri dish. Increased user handling time increases the likelihood for 
human error, especially when maintaining alignment in delicate fibers is important.   
7.3. Limitations 
The data in this project have some limitations to consider, as with any proof of concept 
design project.  
One major question that might be asked when looking at this project is the use of MDA-
MB-231 GFP expressing cells to validate the cell seeding and viability on the customized 
scaffold. These GFP expressing cells were chosen to seed due to their capability to fluoresce 
green under specific wavelength exposure. The limitation in using these cells is that they are 
breast cancer cells. This means that they grow much more rapidly, and in harsher environments 
than non-cancerous cells. The translation between these breast cancer cells to chondrocytes, 
which are the cells in a native meniscus, is difficult. However, the team feels that the use of the 
breast cancer cells was necessary to monitor cell attachment and alignment over an extended 
period of time. The attachment and alignment of breast cancer cells does not mean chondrocytes 
will act in the same manner, but it is a step that supports the viability of chondrocyte use. In the 
end, cells were able to attach to the created scaffold and had access to nutrients, which are two 
key factors in supporting cell life.  
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Related to the use of breast cancer cells to seed the scaffold, the study only involved 
immortalized cell lines that are designed to continue to replicate outside of the body. Because of 
this, the cells continue to proliferate, even when the scaffold reaches its capacity. This prevents 
cells to live on the scaffold, as they overgrow and cannot be passages when seeded on the 
scaffold.  
 Another major limitation to the data is the sample size used in the research. A very small 
number of scaffolds were actually seeded with cells and observed throughout two weeks. The 
small sample size is useful for observing cell behavior, but it is difficult to relate the samples to 
the population of all cells. It is unclear if cells will always act the way the observed cells acted.  
The degradation time of PCL in cell media is another limitation to the data. The PCL 
nanofiber scaffold degraded in 2-3 weeks. Because of this, cell monitoring is not possible past 
three weeks.  
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8. CONCLUSIONS AND RECOMMENDATIONS 
The completion of this project has led to many conclusions, accomplishments, and 
recommendations.   
8.1. Conclusions 
Many conclusions can be made from the research completed in this study. Firstly, custom 
alignment of a nanofiber scaffold was created using a pin matrix collection plate design. This 
creation shows that the pin matrix technique is a viable technology for custom fiber alignment.  
Another conclusion is that electrospun PCL allows for cell attachment and alignment 
along fibers. MDA cells were seeded to the scaffold and were monitored by a fluorescent 
microscope. This is an important conclusion, as cell viability is a key aspect to most created 
scaffold designed for tissue engineering and regenerative medicine purposes.  
The PCL nanofiber scaffold remains in shape for 2-3 weeks when seeded with cells in 
cell media. This means that chondrocyte progenitor cells would have enough time to differentiate 
into chondrocytes once seeded to the scaffold, as this differentiation time is 1-2 weeks long. The 
timeframe of 2-3 weeks will need to be researched further, to determine if that is an ideal time 
frame for degradation for seeded cells to create their own extracellular matrix, or if this 
degradation time needs to be altered by modifying or exchanging the material. 
The optimal weight percent by volume of PCL in HFIP was determined to be 10% for 
electrospinning. This was determined after much research and experimentation. The optimal 
flow rate and voltage range were found to be 0.15ml/hr and 8-12kV. The optimal distance for 
electrospinning was determined to be 15cm.  
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8.2. Accomplishments 
Over the course of the year, the team was able to achieve marked progress and make 
positive strides within each of the three main areas of concentration of collection plate 
development, 3D scaffold production and successful cell adherence to the nanofibrous PCL 
matrix. Each of these areas and the associated sub-accomplishments are evaluated below: 
Collection Plate 
Customizable Grounding 
After initially proving the successful, albeit permanent, grounding abilities of soldering 
each row, the team developed a cluster of brass conductive caps that were custom-fitted to the 
pin diameters, which were then soldering to electrical wiring and merged on the opposite side 
allows for a single alligator clip to be used for the entire set. Using this method the team was able 
to ground various different pin orientations, thus proving the present and future viability of this 
technique.  
Multiple Setup Compatibility 
Even in the short term the team was testing we were able to prove that portions of our 
setup (i.e. collection plate, injection pump, voltage supply) could be switched out and still 
operate effectively in producing fibers. Based on the conducted research, it was also determined 
that this design would be able to work with a gravity-induced electrospinning setup. 
Portable and Straightforward  
As the final collection plate measured a very reasonable 22 x 38 mm, it was highly 
mobile for transportation between labs when brass cap installation or testing warranted these 
location changes. Once the plate was fully manufactured, the plate setup actually only required 
two parts: the main collection plate and the cluster of brass caps soldered, each soldered to an 
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electrical wire. With this minimal setup, the device is very user-friendly and the setup is easy to 
learn for any new individuals going through training. 
3D Scaffold 
Increased Level of Fiber Control 
While the research paper that sparked the interest in pin collection methods proved 
alignment was possible along straight lines, the team took this concept one step further and on 
multiple occasions was able to produce fibers in both straight and curved orientations. This 
proved the advancement of fiber control with our device and the reproducibility by testing 
successfully throughout final prototype testing days. 
Curved Alignment 
As briefly discussed above, the team was able to orient the charged pins along diagonals 
and straight lines within the same orientation and managed to produce a fully-connected 
alignment through the entire charged shape, thus deeming the success of curved fiber shapes.  
Cell Culture 
Cell Adherence 
With 6-8 scaffolds produced with curved fiber alignments tested with cell seeding 
protocols and confirmed by closer inspection with the Salisbury Labs microscopes, the cells 
showed strong adherence to the electrospun fibers. 
Growth Along Fibers 
Expanding upon the above achievement and outlined in our results section, the team 
recognized cells aligning more consistently along the aligned fibers than in the randomly 
oriented, less dense fiber networks.  
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8.3. Recommendations 
There are many areas that this study could be improved through further research. The 
major areas that future research could help improve this project are the following: refining fiber 
removal process, electrospinning with other polymers or with a cell/polymer solution, fiber 
surface coating for cell viability and growth along fibers, improving the process for charging 
collection plate pins, and developing a layered scaffold to achieve different alignments in 3-D.  
The current method of fiber removal from the collection plate is achieved by using 
parafilm that is placed on the pin matrix so that the ends of the pins are exposed. The fibers 
collect on the ends of the pins and the parafilm is then slowly removed from the pin matrix 
taking the fibers with it. The fibers are then removed from the parafilm and placed into a culture 
dish for cell seeding using forceps. The parafilm and forceps fiber removal methods disrupt fiber 
orientation and can damage the fibers very easily. A method of effective fiber removal is an area 
of research for this project and this technology that could help validate customizable fiber 
orientations  
This study focused on electrospinning PCL for scaffolds that were used for cell seeding. 
With cost and availability being large factors as to why PCL was chosen as a polymer for 
electrospinning, no further research was conducted on electrospinning other biomaterials. It 
would be advantageous to conduct further research into other biomaterials that could be used for 
electrospinning and cell seeding. For example, materials such as silk fibroin, collagen, and 
PLGA along with others could be tested to determine how effective they are for electrospinning 
and seeding the scaffolds with cells. Another area of research that could be furthered is creating a 
cell/polymer solution to be electrospun. Therefore, the cells would already be intact with the 
110 
 
scaffold and cell-seeding methods could be bypassed because the cells are already a part of the 
scaffold.  
The PCL scaffolds were seeding with cells without coating or modifying the surface of 
the fibers. Cell viability and adhesion were achieved, however, a study could be conducted on 
the advantages of coating the fibers with collagen or modifying the structure or surface of the 
fibers to promote better cell growth along the fibers, attachment, and proliferation.  
Another area of this study that could be improved is the method of charging the pins of 
interest for customized fiber collection. The current method of the brass caps allows for 
customized fiber alignments to be possible, however, it is a manual application of the caps to the 
pins that is time consuming and tedious. The pins often come out of place because the pins are 
press fit into the collection plate base and are also press fit to the brass caps. Therefore, an 
improved method for charging the pins would be highly advantageous. An automated method of 
pin charging or a much more user friendly manual pin charging method is an area of interest for 
further advancement of this technology. 
Lastly, improvement to the three-dimensionality and layering of the electrospun scaffolds 
could be an area of future work for this study. The current study has developed some three-
dimensionality with the scaffold creation; however, this are can be improved upon. Specifically, 
the scaffold could be layered in three-dimensions so that the fiber alignment could differentiate 
as the scaffold is built upward. For example, a layer of the scaffold could be made with one fiber 
orientation and the next layer of the scaffold could be made with a different fiber alignment. This 
improvement could further help mimic tissues within the body more accurately.  
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Appendix A. Protocols 
Cell Culture Protocol 
Note: This protocol was developed by the Worcester Polytechnic Institute Biomedical 
Engineering Department. 
1. Dilute 0.25% trypsin-EDTA stock 1:5 in 1X Ca++, Mg++ free DPBS to make a 0.05% 
working stock solution. This is done by adding 1 part of trypsin to 4 parts sterile DPBS. Warm 
the working stock to 37o C in the incubator or in a water bath. Return the 0.25% trypsin stock to 
the freezer.  
2. Wipe the outside of the trypsin bottle with 70% ethanol and place it in the culture hood.  
3. Take out the culture dish to be split and place inside the hood.  
4. Aspirate the culture media from the dish using a Pasteur pipette attached to the vacuum pump.  
5. Carefully add 5 ml of Ca++, Mg++ free DPBS to the dish and rinse the cells by gently 
swirling the dish. Do not squirt DPBS directly onto the cells. This might detach cells from the 
dish and be lost while aspirating the DPBS after rinse. 
6. Aspirate DPBS using a Pasteur pipette. Repeat the DPBS rinse once again.  
7. Add 5 ml of warm 0.05% trypsin-EDTA to the dish and incubate at 37 °C in the incubator for 
about 3-5 minutes. 
 8. Observe the dish under a light microscope to see the degree of cell detachment. If the 
detachment is not complete, incubate an additional 2 minutes. If complete, go to the next step.  
9. Using a serological pipette, add 5 ml of complete medium to the dish.  
10. Mix the contents by repeated pipetting to break up cell clumps to individual cells.  
11. Take out a small sample for cell counting if necessary.  
12. Place the tube in the centrifuge along with a balancing tube containing an equal volume of 
sterile water.  
13. Centrifuge the tubes at 200g (RCF) or corresponding RPM for 5 minutes.  
14. Take out the tube and watch for a cell pellet at the bottom of the tube.  
15. Using a sterile Pasteur pipette, carefully remove the supernatant leaving the cell pellet intact.  
16. Re-suspend cells in sufficient amount of complete medium to conveniently split to desired 
number of plates. For e.g., if you are going to split the cell pellet from one T25 flask to two T25 
flasks, re-suspend the cell pellet in 10 ml complete medium. Add 5 ml of cell suspension to the 
two T25 flasks.  
17. Make sure that the media is spread uniformly in the dish by gently rocking the dishes gently.  
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18. Observe cells under an inverted light microscope and transfer the dishes to the cell culture 
incubator for overnight incubation. 
 
Cell Freezing Protocol 
Note: This protocol was developed by the Worcester Polytechnic Institute Biomedical 
Engineering Department. 
Preparation for freezing cells 
A. Prepare enough cryovials for freezing cells. This is done by marking the following details on 
the cryovials using a permanent marker. More specific details that cannot be noted on the 
cryovial should be entered in the freezer log. 
1. Name of cell line or cell type 
2. Passage # 
3. Cell count per vial 
4. Date of freezing 
B. Prepare freezing solution A. This consists of basal media (DMEM) containing 10% FBS (e.g. 
9 ml DMEM + 1 ml FBS). Mix thoroughly. 
C. Prepare freezing solution B. This consists of basal media (DMEM) containing 10% FBS and 
20% DMSO (e.g. 7 ml DMEM + 1 ml FBS + 2 ml DMSO). Mix thoroughly. 
Trypsinization and freezing 
• Trypsinize and re-suspend cells as described earlier. 
• Note the total volume of cell suspension. 
• Load a small amount (~50 ul) into the hemocytometer to determine cell count. Dilute cells if 
necessary. 
• Centrifuge cells at 200xg for 5 to 10 minutes. 
• While the cells are spinning, determine the total cell count. 
• Determine the number of vials to be frozen based on total cell count. For e.g. if you have a total 
of 4 million cells and if you want to freeze @ 500,000 cells per vial you have a total of 8 vials to 
freeze. 
• After centrifugation, aspirate the supernatant carefully without disturbing the pellet. 
• Using a serological pipette, re-suspend the pellet thoroughly by gentle pipetting in half the final 
freezing volume of freezing solution A (4 ml in this example).  
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• Using a fresh serological pipette, add equal amount of freezing solution B slowly (4 ml in our 
example), a few drops at a time while at the same time mixing the contents by gentle rotation or 
inverting the tube. Finally, invert the tube several times to mix the contents thoroughly. 
• Aliquot 1 ml of this mixture into pre-marked cryovials. Make sure to mix the cells 
intermittently lest you end up with vastly different cell numbers in the cryovials as the cells tend 
to settle to the bottom. 
• Cap the vials tightly. 
• Transfer the vials to a freezing container and place in a -80 °C freezer overnight. 
• The following day, transfer the vials to a liquid nitrogen container for long-term storage. 
Cell Thawing Protocol 
Note: This protocol was developed by the Worcester Polytechnic Institute Biomedical 
Engineering Department. 
1. Take out the required number of vials from liquid nitrogen and quickly transfer to a small 
container with lukewarm (not hot) water. The cells will thaw out in about 2 to 3 minutes. 
2. In the meantime, prepare sufficient number of cell culture plates or flasks. Mark the flasks 
with all relevant details that pertain to the cells that you are culturing (cell type, cell #, 
passage #, date etc). 
3. Inside the culture hood, transfer 9.0 ml complete media into a fresh 15 ml conical centrifuge 
tube.  
4. Once the contents of the cryovial have thawed, wipe the outside of the cryovial with 70% 
ethanol and bring it inside the hood.  
5. Carefully open the cryovial. Using a P-1000 pipette or 2 ml pipette, carefully transfer all the 
contents into the centrifuge tube containing 9.0 ml complete media. Close the cap tightly and 
mix the contents by gentle inversion. 
6. Place the tube in the clinical centrifuge. Balance it with a control tube containing an equal 
volume of sterile water. 
7. Centrifuge the tubes at 200g (RCF) or corresponding RPM for 5 minutes. Take out the tube 
and watch for a cell pellet at the bottom of the tube.  
8. Using a sterile Pasteur pipette, carefully remove the supernatant leaving the cell pellet intact. 
9. Using a 10 ml serological pipette, add 10 ml of warm complete media to cell pellet and mix 
gently to disperse the cells uniformly. This can be best accomplished by pipetting multiple 
times and gently forcing the media on to the sides of the centrifuge tube.  
10. After the cells are completely dispersed in the medium, transfer the entire content into a 
sterile culture flask(s). Plate 10 ml per T75 flasks or 100 mm plate. If using this step is 
important to ensure smooth functioning of the centrifuge. Make note of the cell type, passage 
number, cell number per vial, date of freezing and any other relevant details described on the 
vial, cell freezer log or details provided by your instructor. Wear protective eyeglasses and 
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gloves while handling frozen vials in liquid nitrogen. Vials are known to explode as the 
contents in the vial expand rapidly upon thawing due to the dramatic temperature differential 
between liquid nitrogen and ambient room temperature. 25 T25 flasks or 60 mm plates use 5 
ml culture per dish.  
11. Make sure that the media is spread uniformly at the bottom of the dish by gently rocking the 
dishes back and forth and sideways (Do not mix by rotation as this will result in cells 
accumulating in the center of the dish)  
12. Observe cells under an inverted light microscope 
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Appendix B. Gantt Chart 
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Appendix C. Product Codes 
 
Polycaprolactone 
Average molecular weight of 80,000 
Sigma Aldrich product code 440744 
http://www.sigmaaldrich.com/catalog/product/aldrich/440744?lang=en&region=US 
 
1,1,1,3,3,3-Hexafluoro-2-propanol 
Molecular weight 168.04 
Sigma Aldrich product code 105228 
http://www.sigmaaldrich.com/catalog/product/aldrich/105228?lang=en&region=US 
 
